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Preclinical Positron Emission Tomography/Computed Tomography (PET/CT) is a 
well-established non-invasive imaging tool for studying disease 
development/progression, the development of novel radiotracers and 
pharmaceuticals for clinical applications. Over the last five years more than 8,200 
preclinical studies using PET/CT were conducted. Despite this pivotal role, 
standardisation of preclinical PET/CT protocols, including CT absorbed dose 
guidelines, is essentially non-existent. Therefore, the first and second aims of this 
project were: (1) to quantitatively assess the variability of current preclinical PET 
and CT acquisition and reconstruction protocols in routine use across multiple 
centres and scanners; and (2) to propose optimized standardised acquisition and 
reconstruction PET/CT protocols for routine scanning procedures across all sites in 
a preclinical PET/CT laboratory. By assessing quantitative accuracy (known versus 
measured) and precision (reduced variability) of currently used routine protocols 
between five different sites/scanners (Bruker Albira, Mediso nanoPET/CT, Sedecal 
Super Argus, Siemens Inveon and Trifoil LabPET/CT), standard protocols were 
determined. Thereby, irrespective of scanner characteristics the least biased 
empirical quantitative and qualitative protocol results defined the standard protocol. 
In essence, neutralizing the manufacturers' difference, replacing scanner variability 
for scanner similarity to establish global standard protocols.  
 
The analysis of sites’ routine protocol results revealed significant quantitative 
differences between all five sites/scanners. Whereas the standard protocols put 
forth improved accuracy and precision across all sites. Additionally, the large 
disparity and measured amounts of CT absorbed ionising radiation amongst sites 
brought to light the lack of preclinical radiation guidelines and dose regulations. 
Unregulated CT radiation dose is of great concern. CT ionising radiation is known 
to have biological adverse effects. Thus, overexposure of radiation will potentially 
cause unnecessary animal suffering and confound research outcomes. Overall, the 
proposed standard CT protocol reduced radiation doses. The implementation of 
preclinical PET/CT standardised protocols, developed and tested in this project, will 
provide more robust, reliable and reproducible translational data sets for clinical 
applications. In accordance with the National Centre for the Replacement, 
Refinement and Reduction of Animals in Research (NC3Rs) objectives, the 




welfare positively and potentially reduces the number of animals used. Reducing 
study variability in site and across sites through standardisation of protocols 
improves statistically significant results using less animals. 
 
For study specific imaging parameters in preclinical PET/CT rodents are commonly 
used to design the protocol. The third aim of this project strives to develop a tissue 
equivalent material (TEM) anthropomorphic rodent phantom for the replacement of 
animals when designing and optimizing varying in vivo rodent imaging protocols. 
Using a TEM phantom reduces potential biological experimental variability caused 
by the animals and increases reproducibility of findings. To address this aim, 
twenty-four commercially available 3D printing materials were X-rayed for the 
evaluation Hounsfield units (HU). A comparison of calculated 3D material 
attenuation coefficients and accepted tissue attenuation coefficient was also done. 
CT images were acquired using four CT protocols and the developed standard CT 
protocol. Based on measured material HUs compared to accepted tissue/organ HU 
values, four materials were chosen for testing and further evaluation in a 3D printed 
phantom prototype was undertaken. In order to obtain the anatomical features of 
the rodent a CT acquisition of a scheduled 1 rodent was acquired. The CT images 
were used for the 3D printing design. A 3D printed (TEM) anthropomorphic rodent 
phantoms was printed and tested. Measured HU analysis of the phantom TEM 
materials shows promise as a replacement strategy. This imaging protocol 
optimisation approach is also in line with the NC3Rs objective of replacing and/or 







Images acquired by X-rays (CT) are used in assisting doctors to diagnose health 
problems. Another medical imaging technique used by doctors is positron emission 
tomography (PET). Combined with CT imaging this is called PET/CT. In scientific 
research PET/CT is a key tool for disease identification and tracking as well as for 
assessing treatment response and the development of new medicines. The 
information gained from using PET/CT in animal studies can be directly related to 
humans. Therefore, it is imperative that researchers using PET/CT in the laboratory 
have standard procedures/protocols that are followed. Currently, in animal 
(preclinical) research studies using PET/CT no set of standard protocols exist. For 
that reason, this doctoral research project focuses on determining standard routine 
PET/CT protocols for use in research institutes using small laboratory animals. The 
established standard protocol will allow for consistency, reproducibility and 
continuity across research sites and imaging data sets. An additional benefit to 
establishing preclinical protocols is the improvement of animal welfare along with 
the reduction in the use of animals in research. Initiating standard protocols 
eliminates unnecessary repeated studies and thus reduces the number of animals 
used. This will also remove the need for each institute to develop an onsite routine 
PET/CT protocol.  Another important factor for establishing standard protocols is to 
reduce the X-ray doses being absorbed by the laboratory animals. Therefore, 
reducing potential cumulative severity and animal suffering from absorbed X-ray 
dose. The PET/CT protocols determined will be for routine use in preclinical 
research. However, occasionally a study specific PET/CT imaging protocol is 
required. In order to avoid using animals for protocol design, this project also 
focuses on developing a 3D printed plastic model of a rodent. The 3D printed rodent 
model will replace the use of animals in study specific imaging protocol parameters. 
The plastic rodent model will be tested to match rodent tissue densities in order to 
ensure X-rays will pass through the plastic the same way they pass through tissue. 
 
This project collected and analysed PET/CT imaging data and CT dose 
measurements at five different institution. Results clearly showed vast variability 
when using each institution’s own protocols. When using the developed global 
standard protocol data analysis showed significant improvements in accuracy and 
precision across all sites. Adhering to standard PET/CT protocols will immediately 




data sets; establishing a gold standard. This project applies all three of the National 
Centre for the Replacement, Refinement and Reduction of Animals in Research 
(NC3Rs) objectives; refines imaging protocols for reducing the number of animals 
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Whatever disasters befall, do not flinch. 
Go all the bolder to face them, follow your fate to the limit. 
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Figure 1.1: Representative of Chesler’s FBP mathematical concept. Modified from 
Chesler's drawings. 
 
Figure 1.2: A representation of Robertson’s design consisted of a ring containing of 
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Robertson’s drawing. 
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Representation of the X-ray acquisition by multiple angles. 
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mass densities and material type. Also shown are the accepted Hounsfield’s scale 
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data. 
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rays in PET. Modified from University of Washington, Introduction to PET Physics 
by Ramsey Badawi. 
 
Figure 1.7: Drawings of gamma ray events: (A) true, (B) scattered (C) random. 
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Figure 1.9: (A) schematic representing the principles generating Bremsstrahlung X-
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Figure 1.10. Calculated X-ray spectrums (distribution of the number of photons): 
characteristic X-ray spectrum spike for L and K shells and Bremsstrahlung at the 
lower X-ray energies. 
 
Figure 1.11: A: Back projection b(x,y, Φ), into an image reconstruction array of all 
values of p(s, Φ) for a fixed value, p(s, Φ) is the projection formed by integrating 
along the LORs at angle Φ. B: visual representation of FBP. Modified from 
University of Washington, Introduction to PET Physics by Ramsey Badawi. 
 
Figure 1.12: Example of the mathematical sinograms showing detection (A) to 




individual sinograms which also shows difference in size and location of each 
source detected. University of Washington, Introduction to PET Physics by Ramsey 
Badawi. 
 
Figure 1.13: Flow diagram represents the mathematical iterative process for OSEM. 
These steps are repeated until the requested iterations over all projection data is 
completed. 
 
Figure 2.1: Flow chart representing the approach/process of image data analysis: 
acquisitions with the IQ phantom and the PET rod spatial resolution phantom; 
multiple reconstruction methods for quantitative analysis; default and standard 
reconstruction methods for visual analysis. 
 
Figure 2.2: Screen shot of the Mediso’s MATLAB software tool for the PET IQ 
analysis displaying the regions of the IQ phantom (uniformity, RC and SOR) as well 
as the placements of the regions. Panel (A) top down shows the placement of the 
ROIs (each hot rod) for RC, panel (B) top down show the placement of the uniformity 
ROI and panel (C) shows the placement of the ROIs for the spill-out ratio, white air 
chamber, blue water chamber. 
 
Figure 2.3: PMOD screen shot showing the VOI placement on the PET IQ uniformity 
region for SUV measurements. Panels (A), (B) and (C) display the VOI placement 
from axial, sagittal and coronal views respectively. 
 
Figure 2.4: Recovery coefficients (RCs) for hot rods of 1, 2, 3, 4 and 5 mm of the 
PET IQ phantom extracted for each scanner. Panel (A): default reconstruction 
iterative methods. Panel (B): displays RCs with standardisation of iterative methods 
of reconstruction. Panel (C): RCs for each site using FBP reconstruction with the 
exception of scanner 4 (reconstruction option not available yet). 
 
Figure 2.5: Image slice through the uniformity section of the PET IQ phantom for 
each scanner shows variability in scanner uniformity as well as SUV measurements 
when using the scanner default and varying reconstruction protocols. Panel (A) 
shows the default, panel (B) the standard and panel (C) displays the FBP 
reconstruction method. 
 
Figure 2.6: Image slice and horizontal profile through the PET rod phantom. Panel 
(A): Scanners 2, 3 and 5 resolved 2.0, 1.5 and 1.2 mm rods using default 
reconstruction protocols. Panel (B): Standardised reconstruction methods improved 
the spatial resolution of scanner 4 (2.0 and 1.5 mm rods are seen) and essentially 
did not change the spatial resolution of scanner 5. Panel (C) shows the QRM hot 
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Figure 3.1: Flow chart representing the approach/process of image data analysis: 
acquisitions with the air/water and TEM phantom for quantitative HU analysis; CT 
bar phantom default and standard acquisitions for visual analysis. Absorbed dose 





Figure 3.2: PMOD screen shot showing the VOI placement on the CT water and air 
region for HU measurements. Panel (A) provide an axial view point and panel (B) 
displays a coronal view showing the water (left) and air (right) chambers. 
 
Figure 3.3: PMOD screen shot showing the VOI placement on the CT TEM phantom 
rods for HU measurements. Panel (A) (axial view) and (B) (coronal) show the 
different size rods.  
 
Figure 3.4: Schematic representation of panel (A) in Figure 3.3 showing the location 
and identification of the rods, along the manufactures reported densities. Rods 1- 4 
are 4 mm, rods 5-8 are 2 mm, rods 9 and 11 are 4 mm and rod 10 is 5 mm. 
 
Figure 3.5: Clearly seen in the water section of the CT air/water phantom are ring 
artefacts. Scanners 1, 3 and 4 all have a centre of rotation error. This error can be 
corrected for by running the scanner calibrations. Scanner 5, however, has a 
detector error, which will require replacement.  
 
Figure 3.6A: CT TEM, air and water HU results. For each material, each data point 
represents a measurement from a scanner (n=3) from four different sites. Densities 
1.08 to 1.57 g/mL include rod sizes 2 mm and 4 mm as reported by the 
manufacturer. The x-axis clearly shows the spread of HU values per density (A) and 
displays the significant variations measured using the default protocols (p<0.0001, 
one-way ANOVA, n=3 per group).  
 
Figure 3.6B: CT TEM, air and water HU results. For each material, each data point 
represents a measurement from a scanner (n=3) from four different sites. Densities 
1.08 to 1.57 g/mL include rod sizes 2 mm and 4 mm as reported by the 
manufacturer. Panel (B) clearly shows improved precision across scanners and 
densities when using the standardised protocol. 
 
Figure 3.7: Plotted scanner's outputted grey scale values for CT TEM phantom. 
Grey scale results shows linearity. 
 
Figure 3.8: CT bar phantom images displaying QRM pattern for spatial resolution 
using the default (A) and post standardisation (B) of CT protocols. 
 
Figure 4.1:(A) schematic representing the principles of generating Compton 
scattering. (B) schematic representing the principles the Photoelectric effect. 
 
Figure 4.2: Drawing represents the ranges of accepted clinical HU values. 
 
Figure 4.3: Drawing represents the experimental design measuring each material's 
attenuation coefficient varying tube voltage and material thickness. The thickness 
of each material was varied by changing the material position, i.e. different 
thickness are shown in (A) and (B). 
 
Figure 4.4: Photographs of selected 3D-printing materials used in this study. (A) 




A to E there is a change in material density. Panel (F) is a representative image 
(axial and coronal planes in display) showing VOI placement on the CT acquisition 
for each material for HU measurements (F). 
 
Figure 4.5: Flow chart representing the approach/process of image data analysis: 
CT acquisitions, surface rendering of DICOM files, conversion to SLT, export to 
CAD. for 3D printing preparation. 
 
Figure 4.6: Images showing rodent CT acquisition, surface rendered whole body 
and skeleton to image of whole body and skeleton in CAD software prior to any 
repairs. 
 
Figure 4.7: Shows the STL files as seen in the CAD software. Panel (A) displays 
the mesh file voids/holes, overlapping surfaces and artefacts. Panel (B) represents 
the beginning process of removing artefacts and repairing. Panel (C) shows the 
outlined version of the cleaned file. 
 
Figure 4.8: The skeleton after being removed from the whole body is shown at its 
final stage for printing. The 3D printing of the skeleton file is done in the whole body 
and separately. 
 
Figure 4.9: Similar to Figure 4.7, Panel (A) represents the beginning process of 
removing artefacts, repairing and rebuilding for the brain. Panel (B) shows the same 
for the heart. 
 
Figure 4.10: Shows the STL files as seen in the CAD software and the fully repaired 
version. Both panel (A) and (B) are zoomed in views. Panel (A) is the close up of 
the head showing the striking difference before and after file repairs. The same is 
true for the abdomen in panel (B). 
 
Figure 4.11: Image from the CAD software showing the mesh file repaired, rebuilt, 
cleaned and all vertexes aligned for printing. The phantom whole body with internal 
organs and skeleton can clearly be seen in panel (A). Panel (B) shows the split 
which allows for the removable of scaffolding material in the lungs. 
 
Figure 4.12: PMOD screen shot showing the VOI placement on the CT acquisition 
on the Tango and Vero Clear 3D printing phantom. Panel (A) is the placement on 
the brain, panel (B) displays the placement for the lung (green), heart (dark blue) 
and CaHA capsule (light blue) and panel (C) shows the liver (pink) and both kidneys 
(orange and red). 
 
Figure 4.13: Calculated attenuation coefficient curves for all nine 3D-printing 
materials. Though values were calculated from 5 keV to 135 keV displayed is 30 
keV to 120 keV for visual distinction between materials. 
 
Figure 4.14: Material Endur calculated X-ray fluence spectrum. Data presented as 





Figure 4.15: Material Endur calculated spectrum at the X-ray tube voltage of 125 
kVp, shown per material thickness. 
 
Figure 4.16: Spectrums of the material Endur showing X-ray tube voltage of 102 
(A), 81 (B), 70(C) and 60 (D) kVp for the 5 different thicknesses in which a 
measurement was obtained, with Bremsstrahlung X-rays clearly dominating at the 
lower energies. 
 
Figure 4.17: Comparison of calculated 3D material Endur at the X-ray tube voltage 
125 kVp to each measured output at the defined thicknesses (0.5, 0.7, 2.9, 5.8 and 
15 cm). 
 
Figure 4.18: Comparison of calculated 3D material Endur at the X-ray tube voltage 
of 102, 81, 70 and 60 kVp to each measured output at the defined thicknesses (0.5, 
0.7, 2.9, 5.8 and 15 cm). 
 
Figure 4.19: Comparison of calculated material linear attenuation coefficients to 
accepted muscle tissue attenuation coefficients. Strong correlation between 
calculated and accepted is seen at energies above 75 keV and less so as the 
energy decreases. 
 
Figure 4.20: Comparison of calculated material linear attenuation coefficients to 
accepted bone attenuation coefficients. A decent correlation between calculated 
and accepted is seen at energies above 90 keV but substantial differences are seen 
less than 90 keV. 
 
Figure 4.21: Comparison of calculated material linear attenuation coefficients to 
accepted lung tissue attenuation coefficients. Clearly evident, no material displayed 
a close similarity to lung. 
 
Figure 4.22: CT images shown are with the standard protocol acquisition. Panel (A) 
is the printed prototype, (B) is the split phantom for testing HU. Panel (C) is a 
separate CT image of the skeleton, maximum intensity projection (MIP) image. A 
calcium hydroxyapatite (CaHA) capsule was imaged inside the lung for HU analysis 
in the phantom (B) and the skeleton (C). 
 
Figure 4.23: CT images of the split phantom for each CT acquisition protocol; (A) 
standard; (B) default; (C) low dose; (D) high dose.  
 
Figure 4.24: HU values measured from the 3D printed phantom using the four CT 
protocols according to Table 4.8. 
 
Figure A1.1: Modified drawing from Dr Adam Alessio showing the difference 
between 2D and fully 3D measurements [1]. (A): Displays detectors with septa, in 
which 2D modes collects projection data in the direct and cross planes. (B): 
Represents the collection of fully 3D projection data, no septa allowing collection 






Figure A3.1: CT TEM, air and water HU results for tested protocol with 170 
projections. For each material, each data point represents a measurement from a 
scanner (n=3) from four different sites. Densities 1.08 to 1.57 g/mL include rod sizes 
2 mm and 4 mm as reported by the manufacturer. The x-axis clearly shows the 
spread of HU values per density.  
 
Figure A3.2: CT TEM, air and water HU results for tested protocol with 480 
projections. For each material, each data point represents a measurement from a 
scanner (n=3) from four different sites. Densities 1.08 to 1.57 g/mL include rod sizes 
2 mm and 4 mm as reported by the manufacturer. The x-axis clearly shows the 
spread of HU values per density - though not as bad as the 170 data.  
 
Figure A3.3: CT TEM, air and water HU results for tested protocol with 720 
projections. For each material, each data point represents a measurement from a 
scanner (n=3) from four different sites. Densities 1.08 to 1.57 g/mL include rod sizes 
2 mm and 4 mm as reported by the manufacturer. The x-axis clearly shows the 
spread of HU values per density, similar to the 480 projections.  
 
Figure A5.1: Spectrums of the material Perspex showing X-ray tube voltages of 
102, 81, 70 and 60 kVp for the 5 different thicknesses in which a measurement was 
obtained. 
 
Figure A5.2: Spectrums of the materials Med 160 showing X-ray tube voltages of 
102, 81, 70 and 60 kVp for the 5 different thicknesses in which a measurement was 
obtained. 
 
Figure A5.3: Spectrums of the materials High Temp showing X-ray tube voltages of 
102, 81, 70 and 60 kVp for the 5 different thicknesses in which a measurement was 
obtained. 
 
Figure A5.4: Spectrums of the materials Vero Clear showing X-ray tube voltages of 
102, 81, 70 and 60 kVp for the 5 different thicknesses in which a measurement was 
obtained. 
 
Figure A5.5: Spectrums of the materials Vero White showing X-ray tube voltages of 
102, 81, 70 and 60 kVp for the 5 different thicknesses in which a measurement was 
obtained. 
 
Figure A5.6: Spectrums of the materials Vero White Plus showing X-ray tube 
voltages of 102, 81, 70 and 60 kVp for the 5 different thicknesses in which a 
measurement was obtained. 
 
Figure A5.7: Spectrums of the materials Tango Black showing X-ray tube voltages 
of 102, 81, 70 and 60 kVp for the 5 different thicknesses in which a measurement 
was obtained. 
 
Figure A5.8: Spectrums of the materials Tango Black Plus showing X-ray tube 
voltages of 102, 81, 70 and 60 kVp for the 5 different thicknesses in which a 





Figure A6.1: Comparison of calculated 3D material Tango Black at the X-ray tube 
voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
Figure A6.2: Comparison of calculated 3D material Tango Black Plus at the X-ray 
tube voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
Figure 6.3: Comparison of calculated 3D material High Temp at the X-ray tube 
voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
Figure A6.4: Comparison of calculated 3D material Med 160 at the X-ray tube 
voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
Figure A6.5: Comparison of calculated 3D material Vero Clear at the X-ray tube 
voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
Figure A6.6: Comparison of calculated 3D material Vero White at the X-ray tube 
voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
Figure A6.7: Comparison of calculated 3D material Vero White Plus at the X-ray 
tube voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
Figure A6.8: Comparison of calculated 3D material Perspex at the X-ray tube 
voltage of 125,102, 81, 70 and 60 kVp to each measured output at the defined 
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Chapter One: Introduction 
 
1. Role of preclinical Positron Emission Tomography/Computed 
Tomography (PET/CT) in biomedical research 
 
Preclinical PET/CT is a key non-invasive imaging tool in biomedical research. It 
allows for reduction of the number of animals used, while simultaneously improving 
statistical power by using each animal as its own control in longitudinal studies, with 
consequential scientific benefit. Diagnostic and therapeutic agents can be 
developed and tested on identical platforms to human, thus accelerating the 
translational process [2–5]. The continued increased usage of preclinical PET/CT 
imaging in research has stimulated efforts to develop optimised standard 
acquisition and reconstruction protocols. Optimisation of preclinical acquisition and 
reconstruction protocols will have a widespread impact across several biomedical 
research fields using PET/CT, including: biomarker research [6–8], research in 
neurodegenerative diseases, cardiovascular diseases [9–13], metabolic diseases, 
musculoskeletal disorders and oncology [14–17]. 
 
Despite this pivotal role, global standardisation of acquisition and reconstruction 
preclinical PET/CT imaging protocols is still lacking. This is completely the opposite 
from clinical PET/CT in which standardisation of imaging protocols and system 
calibration are the norm with established guidelines from the National Electrical 
Manufactures Association (NEMA) and the American College Radiology Imaging 
Network (ACRIN). To date the majority of studies looking into preclinical PET/CT 
optimisation of acquisition and reconstruction protocols have been performed 
primarily using the manufacturers default protocol or slight variations thereof [18,19]. 
Therefore, the impact of varying PET/CT parameters on preclinical data and 
preclinical research results is poorly defined and not fully understood. Furthermore, 
the significance of different CT parameters on radiation exposure to small laboratory 
animals is scarcely described in the literature [20,21], in particular cumulative severity 
for longitudinal studies. Given that cumulative radiation doses can become 
increasingly toxic [22], accurate CT absorbed dose measurements are essential 
when undertaking longitudinal preclinical research. This is most relevant and 
obvious when working with rodent tumour models in order to assure a clear 
distinction between diagnostic radiation imaging and radiotherapy [20,22–25]. 
Systematically and comprehensively this doctoral research addresses such lack of 




across centres using default scanner protocols, followed by developing 
standardised protocols for optimisation of PET/CT imaging at multiple centres. 
Empirically known quantitative image acquisition results from the various scanner 
protocols provides the opportunity to establish global standard protocols, replacing 
variability for similarity. 
 
The fundamental principles and mechanisms of standardisation are intertwined with 
the development and evolution of the PET/CT scanner. Chapter 1 provides a brief, 
chronological narrative of PET, CT and the fusion of the two pointing out the 
beginnings of standardisation. Unfortunately, to date this standardisation only 
applies to clinical PET/CT. 
 
2. Brief chronological development and principles of PET and CT 
  
 2.1. PET 
 
The roots of positron emission tomography can be traced back to the early days of 
radioisotope research and span several decades of physics, chemistry, 
mathematics, engineering, material and computer science research [26,27]. Each 
field was required in order for PET to become a mainstay as a clinical and preclinical 
nuclear imaging tool. 
 
The primary success of PET is due to the fact that Nobel Laureate physicist Paul 
Dirac theoretically postulated the existence of an electron with a positive charge 
(e+). In his 1928 paper, Dirac stated: “The true relativity wave equation should thus 
be such that its solutions split up into two non-combining sets, referring respectively 
to the charge e- and the charge e+” [28]. Dirac also noted that experimentally, the 
electron, when transitioning would appear as suddenly changing its charge from e- 
to e+ [28]. This provided the opportunity and eventually led to Nobel Laureate 
physicist Carl Anderson experientially proving the existence of an electron with a 
positive charge: the realization of the positron [29]. Expanding on Dirac’s theory, 
many years later Nobel Laureate physicist Richard Feynman computationally 
claimed that positrons were actually virtual electrons scattered backwards in time 
to annihilate an electron [30]. This electron positron annihilation is key to PET. For 
when an electron and positron annihilate two gamma rays with energy of 511 keV 
are emitted at 180 ± 0.6 degrees (opposite directions) due to the conservation of 
momentum [31,32]. Regardless of the direction or nature of the positron, it is the two 




dependability on the detection of the two gamma rays, from the annihilation, means 
positrons are needed. Hence, the production of positron emitting radioisotopes is 
required for imaging.  
 
Physicist Dr Ernest Lawrence’s resolve to research the nucleus lead to the 
successful production of artificial radioactive elements (radioisotope); winning the 
1939 Nobel Prize in physics "for the invention and development of the cyclotron and 
for results obtained with it, especially with regard to artificial radioactive elements". 
Simply described in his 1932 paper:  
 
 Semi-circular hollow plates, not unlike duants of an electrometer, are 
 mounted with their diametral edges adjacent, in a vacuum and in a 
 uniform magnetic applied to the plate electrodes producing an 
 oscillating electric  field over the diametral region between them 
 [33,34]. 
 
In his Nobel Prize lecture, Lawrence not only gracefully acknowledged the work 
done by Nobel Laureates Frédéric and Irène Joloit-Curie, in which their paper 
announced the production of artificial radioactive elements, but also put forward 
questions and designs for further research in radioactive elements [35]. Lawrence’s 
continued development and successful work with the cyclotron eventually yielded 
the production of positron emitting radioisotopes for PET such as carbon-11 (11C), 
nitrogen-13 (13N), oxygen-15 (15O) and fluorine-18 (18F) [34]. 
 
After the design, the capability to actually detect the 511 keV gamma rays was 
required. The concept of using, detecting and measuring radioisotopes (nuclear 
medicine) fundamentally started in the 1940 with the use of Geiger-Muller counters 
[36]. Then in 1951 with the use of improved developed scintillation counters Wrenn 
et al. (1951) published the design and results of their novel PET system [37]. This 
new approach took advantage of the resulting gamma rays from the positron 
electron annihilation. Wrenn clearly stated their design was founded on the two 
gamma rays which “emerge simultaneously and oppositely directed, with a 
precision of 1/137 radian…to count these 2–γ rays in coincidence, the source of 
activity must then lie somewhere on a straight line joining the 2 counters” [37]. 
Independently, the same year physicist Dr Gordon Brownell’s research using 
coincidence PET detecting was also tested and published by Sweet et al. (1951) 
[38,39]. Though both Brownell and Wrenn focused on brain tumour detection, Wrenn 




testing sodium-22 (22Na). Regardless, the designs and results provided great 
promise for future coincidence counting. 
 
Brownell’s group at the Physics Research Laboratory at Massachusetts General 
Hospital (MGH) went on to develop the first recognized PET systems for clinical 
and preclinical usage as well as continuing with the development and enhancement 
of future PET systems. For example, one of the first improvements to PET came in 
the form of a mathematical reconstruction method instead of hardware. Expanding 
on the conventional back projection method for reconstruction group member Dr 
David Chesler developed the algorithm filtered back projection (FBP), applying a 
filter in order to reduce blurring. Implementing this algorithm to PET and CT 
substantially improved image quality. Dr Chesler's conceptual drawing is shown in 
Figure 1.1 [40–43]. 
 
Figure 1.1: Representative of Chesler’s FBP mathematical concept. Modified from Chesler's 
drawings [42,43]. 
 
As reconstruction algorithms improved - next so did the PET system designs. By 
1973 Dr J.S. Robertson working at Brookhaven National Laboratory designed and 
constructed a system with 32 detectors in a ring formation as opposed to Brownell’s 
parallel detector systems. Unfortunately, and as Robertson noted, “In its present 
form the system does not give as good spatial resolution as do others… but there 
is a potential for improvement” [44]. However, the relevance and impact this design 
had on the advancement of PET becomes obvious when simply viewing 21st century 






Figure 1.2: A representation of Robertson’s design consisted of a ring containing of thirty-
two 3.2 cm scintillation crystals with electronic cabling for detecting every crystal pairing in 
coincidence, represented by the arrows. Modified from Robertson’s drawing [44]. 
 
Shortly thereafter, in 1974 biophysicist Dr Michael Phelps, nuclear chemist Dr 
Edward Hoffman from Washington University in St. Louis, Missouri and with 
physicist Dr Michael Ter-Pogossian, in collaboration with the company EG&G 
ORTEC (Oakridge, Tennessee, USA) built what is consider the first fully functional 
PET scanner, officially coining the acronym PET. This newly designed hexagonal 
PET scanner (PET III) consisting of 48 scintillation crystals successfully produced 
improved quality images [40,45]. The PET III also included its own computer for 
controlling a 60-degree rotation of the gantry, the motion of the detectors, the bed, 
a display and performing image reconstruction [27,38,42,46,47]. Based off the PET III 
design EG&G ORTEC built the first commercial PET scanner installed in 1976 at 
the University of California, Los Angeles. It now might appear as if PET, proven 
worthy, would take off as an integral component, imaging tool for the 
clinics/hospitals while continuing to be at the forefront of nuclear medicine research 
[38]. 
 
This unfortunately was not to be – yet. Though the results, images acquired using 
PET from brain tumour and blood flow studies proved coincidence positron 




scatter corrections, system sensitivity and attenuation corrections. At this point, it 
should be noted one aspect of the research done by Phelps and Hoffman set the 
foundation for testing the intrinsic and extrinsic characteristics of PET, essentially 
establishing future calibration testing and clinical standardisation. Their work in 
1974 addressed and analysed the spatial resolution and contrast, depth 
independent resolution and sensitivity, pulse height analysis, accuracy of 
attenuation correction methods and the efficiency of the detectors. They also 
included testing what is now called spill out ratios (SOR) and recovery coefficients 
(RC) using hot and cold spots as well as small rods (1 cm – 3.5 cm) within a 
phantom. Such testing became fundamental in establishing the performance of a 
scanner. SOR measured the ratio between regions of no activity concentration 
(cold) to the mean activity (hot) in the background, indicating the scatter correction 
performance of the scanner. The RC measurement reflects the scanner’s inherent 
limited spatial resolution [42].  
 
Advancement of PET lay in the improvement of scintillation detectors and the 
development of radiopharmaceuticals (radiotracers). First, in order to detect, 
collect, and count coincidence gamma rays an efficient detector system is 
paramount. The basic set up for the detection of the gamma rays (photons within 
the accepted energy range/threshold) includes scintillator crystals, a light guide and 
photomultiplier tubes (PMT). The concept is straightforward; photons reach the 
crystals, the crystal converts the photons to light, next PMTs capture (by a 
photocathode) the light converting it into photoelectrons then moving (by an electric 
field) them through a set of plates (dynodes) multiplying the number of 
photoelectrons via a potential difference across the dynodes to be read out as the 
signal. 
 
Initially PET detectors used thallium doped sodium iodide NaI:Tl scintillating 
crystals, as they possess qualities required for photon detection. For acceptable 
detection scintillation crystals need to have at least three main features: good 
stopping power (ability to stop the incoming photons, dense and high Z number), 
fast light pulse rise and decay times (fast increase in light intensity and fast 
exponential decrease of maximum intensity) and high optical light transmission 
(high light output). For the most part NaI:Tl crystals met such requirements with the 
exception of not having great stopping power. They were and still are commonly 
used due to their high light output [48–50]. In the late 1970s bismuth-germanate 




manufacturing. Currently, BGO has been deemed the primary crystals for PET 
detectors even though its light output is substantially lower then NaI:Tl crystals.  
Improvements continue. For example, lutetium (yttrium) oxyorthosilicate crystals of 
various doping (LYSO:Ce and LSO:Ce) have moved into the forefront of research 
for PET usage given their high light output, density and Z number, though they 










































































































































Second, the successful development of PET radiotracers plays a significant role. In 
Missouri at Washington University blood flow studies with PET imaging using 11C-
labelled glucose proved successful. However, it was Sokoloff et al. (1977) with the use 
of 14C-labelled deoxyglucose for measuring glucose utilization in the brain that lead the 
way for the synthesis of 18F-deoxyglucose, [18F]FDG at the Brookhaven National 
Laboratory [52,53]. In collaboration with the University of Pennsylvania and the National 
Institutes of Health the Brookhaven group using their novel synthesized [18F]FDG set out 
to determine its metabolic properties. Gallagher et al. (1978) concluded this metabolic 
trapping could be a principle radiotracer for probing function or tumour location in PET; 
“The tissue content of 18F radioactivity that can be measured in vivo by tomographic 
techniques might provide a measure of the ability of the brain and heart to transport, 
phosphorylate, and thus utilize glucose in vivo” [54]. This led to the expansion of PET 
research, extensively covering studies in multiple organs, no longer just in the brain, 
heart and lungs or blood flow. Numerous studies were being done covering biochemical 
and metabolic characterization of diseases, including the diagnosis, progression or 
regression of tumours. Today, even though PET is still facing challenges due to limits in 
spatial resolution and scatter correction, over the last five years alone, more than 32,000 
research papers reported the use of PET imaging (preclinical and clinical, ISI Web of 
Science, search conducted on the 21st October 2017 with key words “positron emission”). 
 
Clearly, PET has become an integral component in medical imaging. Again, it should be 
stated that along PET’s arduous path of development the standards for clinical scanner 
calibrations were established; acceptable intrinsic and extrinsic “gold standards” for 
quality and quantification assurance. Clinical standards that include scanner patient 
protocols were also designed and implemented, NEMA and ACRIN [55,56]. Unfortunately, 
until 2019 such standards were essentially non-existent in the preclinical imaging 
platform. This void in preclinical standardisation is the rationale behind this study. 
 
 2.2. CT 
  
CT did not have nearly as arduous a path towards successful acceptance as did PET. 
CT is a tomographic methodology devised by engineer Sir Godfrey Hounsfield that was 
immediately met with approval and implemented, (winning the Noble Prize for Physiology 




(radiograms/radiography) was accomplished by exposing an X-ray beam to the desired 
area of an object with a photographic plate underneath in order to detect the remnant 
beam. This meant that the X-ray beam and specific plane in the object stayed in focus 
on the plate causing X-ray projections elsewhere to be blurred. The acquired images 
were superimposed upon each other but due to blurring the desired imaged structure 
had to compete against any structure above or below it. The resulting images were of 
poor quality and offered no accurate quantitative analysis. Hounsfield in 1973 pointed 
out conventional radiography was clearly not efficient, as essentially 90% of the 
information collected was not utilized and created artefacts as 2D images were 
converted to 3D [40,57,59]. 
 
The use of a narrow X-ray beam, as proposed by Hounsfield, fundamentally created 
slices through sections of the structure and acquired images at several angles, “a series 
of contiguous cross sections”. Therefore, upon reconstruction the acquired slices where 
not hindered from any variations in the slices on either side, as the radiation is “confined” 
to each individual slice [59]. A diagram of the conventional process of capturing the 
shadow is shown in Figure 1.3 along with Hounsfield’s design. 
















Figure 1.3: Modified Hounsfield’s drawings of the method for X-ray acquisition. (A): the 
conventional method with a photographic plate underneath the patient. (B): Hounsfield’s purposed 




The impact of this new method for acquiring and reading X-ray transmission images was 
immediate. The sensitivity was substantially improved merely by the number of photons 
being detected due to the increase of angles acquired. The narrow X-ray beam slice 
acquisitions allowed for the unencumbered superimposing of the slices/images from 2D 
to 3D. For the first time, unlike conventional X-ray, CT was able to distinguish the 
different densities between various soft tissues such as kidneys and liver. CT allowed for 
quantitative measurement of different tissue densities via X-ray, not just an overall mean 
X-ray absorption of all soft tissues as previously done.  
 
Fortunately for Hounsfield, the computing power required to handle and process 
approximately 28,000 transmission projections existed in the 70’s, as did the 
reconstruction method necessary to obtain the CT images, i.e. FBP. Therefore, CT made 
an easy transition into clinical use, while increasing its usefulness in clinical and 
preclinical research.  
 
The first commercially available CT (EMI Ltd.), based on Hounsfield’s system, detected 




acquisitions over 5 minutes. Though acquisition times would eventually be reduced, even 
by the 70's clinical standards for absorbed radiation doses had been in place for roughly 
20 years [60,61]. Generally, todays’ CT beam slice thickness can be as small as 0.625 
mm, detected by garnet ceramic scintillation crystals coupled to a photodiode array, with 
gantries having a 0.25 sec rotation speed for shorter scan times [62]. However, absorbed 
ionized radiation dose remains a concern in the clinical setting. A concern readily ignored 
in preclinical research, evident by non-existent standards and guidelines. This doctoral 
project addresses this deficiency by establishing PET/CT standards.  
 
Analogous to the accomplishment and implementation of CT was the development of a 
scaling factor for quantifying and verifying the accuracy of the distribution and attenuation 
of X-ray transmission through tissue. In order to assess X-ray attenuation numerical 
values were ascribed, relating to the attenuation calculations (attenuation coefficients) to 
tissue densities [28,59,63–65]. Considering X-ray absorption through water is similar to soft 
tissue, water was set to be 0, with air set at -1000. These values are known as Hounsfield 
Units (HU), used to differentiate and compare tissue densities. Though HU values are 
taken as absolute values they are in fact, as stated, a scaling factor. Attenuation 
coefficients are dependent on the energy of the X-ray beam being emitted and the 
material the X-rays pass through. Therefore, each CT system will generate slightly varied 
HU numbers. Due to this variation scanner calibration requirements were established 
and required for clinical use, ensuring quality assurance. Unfortunately, no such 
calibration requirements exist in preclinical CT. 
 
Hounsfield’s first CT scanner included placing a water tube around the patient’s head in 
order to correct for beam hardening (lower energy X-rays being absorbed, leaving high 
energy X-rays). This was essentially providing the attenuation coefficient of the water, 
which was compared and used to determine X-rays attenuation in soft tissue, as seen in 
Equation 1.1 and 1.2:  
 
𝑋(#$) = (𝑋' −	𝑋*) = (μ+ − 	𝜇*) +	(μ. −	𝜇*) +	(μ/ −	𝜇*) +	⋯⋯+(μ1 −	𝜇*)  








Therefore, CT numbers (HU): 
 
𝐶𝑇 = 	1000 (μ67	89)
89
	         Eq. (1.2) 
 
In Equation 1.1 and 1.2, 𝑋' represents the soft tissue and 𝑋* the water. The attenuation 
coefficients are represented by μ' and μ* for the soft tissue and water respectively 
[57,59,66]. 
 
As straightforward as the CT HU Equation 1.2 is, the delineation of the different tissue 
densities is actually far more convoluted. This is essentially due to tissue inhomogeneity, 
CT system used for data acquisition, the spectrum of X-ray energies and scatter [67].  
 
Furthermore, the scaling relationship of soft tissue and bone is nonlinear, with a 
discontinuity around 300 HU. Research in 1994 by LaCroix et al. on combined single 
photon emission computer tomography with CT (SPECT/CT) investigated using the 
acquired CT data for attenuation corrections [68]. They found a substantial difference in 
the calculated accuracy of the attenuation coefficients between soft tissue and bone. In 
conclusion, their results indicated the attenuation coefficients for soft tissues (lung and 
muscle) were accurately estimated, bone was not. They suggested bone required a 
different scaling factor from soft tissue. Figure 1.4, a calibration curve, (mass density 





Figure 1.4: Typical (HU, ρ) calibration curve used for the conversation of HU into mass densities 
and material type [69]. Also shown are the accepted Hounsfield’s scale intervals for different 
materials (-1000 to 1000 HU) based on previously published data [57]. 
 
Bilinear scaling algorithms have been developed using 300 HU as threshold (above or 
below) others simply use >0 HU or < 0 HU. DeMarco et al. (1998) in establishing a Monte 
Carlo simulation tool for dosimetry planning and analysis divided tissue into six 
categories (lung, air, fat, muscle, water and bone), as well as other subgroups based on 
a mass density calibration curve [70,71]. Schneider et al. (1996 & 2000) developed 
stoichiometric methods to create groups based on the CT HU scale. The method derived 
the functional relationship between CT numbers and tissues by defined groupings, (-
1000 to -98 HU, -98 to 100 HU and >100 HU) in which the tissue mass density and 
elemental weights were calculated using either a step function or interpolated [71,72]. 
 
The relevance of knowing HU and their limitations is far from trivial. Here, HU values will 
be used for the development of preclinical anthropomorphic phantoms when assessing 
3D printing materials for soft tissue to bone. Converting attenuation coefficients to HU 
allows for comparable values across different CT scanners. Therefore, direct 
comparisons between scanners enrolled in the study can be achieved. Questions 




HU values each scanner measures for different tissues? How does each scanner’s 
extracted HU measurements compare? How do these preclinical HU values compare to 
accepted clinically measured HU? 
 
 2.3. Fusion of PET and CT 
 
Though not a novel idea, in 2000 integrating PET with CT for co-registration of functional 
and anatomical information was new and presented problems. Notwithstanding, Dr 
Thomas Beyer et al. (2000), University of Pittsburgh, published the design and results of 
the first PET/CT manufactured in collaboration with Siemens [73]. Their original concept 
purposed and designed a clinical oncology scanner, which produced high spatial 
resolution anatomic CT images to be co-registered with functional PET images. This 
allowed for the avoidance of patients being scanned on two separate systems then the 
process of correlating the images from two scanners. Therefore, the primary goal was 
the precise identification of the distinct anatomical region of the PET radiotracer [74]. 
 
As a by-product, generating CT attenuation correction maps for PET was developed. 
Attenuation corrections for PET had previously been done by acquiring a “blank” (no 
patient in the bore) transmission scan using a radioactive rod (usually caesium-137 (137 
Cs) or germanium-68 (68Ge) of a known activity) then applying the calculated corrections 
to the scanner [75]. Patient PET attenuation correction image data was acquired as a 
68Ge transmission scan of the patient then applying the corrections Using the patient’s 
own CT scan anatomical information removed the need for a separate transmission scan 
being applied to the patient’s scan and avoided co-registering separate data 
sets.[32,73,76,77]. 
 
Converting CT quantitative attenuation coefficients are fundamental in generating 
attenuation correction maps for PET. However, this conversion to PET posed several 
problems. Such as, accounting for motion corrections. Another crucial concern revolved 
around the conversion of HU for PET. Different photon energies are a concern as PET 
is mono-energetic with 511 keV and CT is a polychromatic X-ray range usually from 35 
to 160 keV. Furthermore, energy dependent attenuation (absorption/scatter) processes 
for PET and CT differ: Compton scattering versus photoelectric absorption in denser 
materials (bone) and Compton scattering in less dense material (soft tissue). In order for 




numbers (HU) need to be scaled to match PET [ 78–80]. Under the guidance of the group 
from the University of Pittsburgh, in conjunction with the development and enhancement 
of PET/CT, Kinahan et al. (1998 & 2000) addressed the application of CT attenuation 
coefficients for PET. This early work presented the feasibility of CT based corrections 
via phantom and human studies by using methods of scaling, segmentation, hybrid of 
the two and dual-energy and later simulation. The results proved the practicality of all 
the methods but with the segmentation producing the most accurate attenuation 
coefficients. Notably, in this work a CT effective energy of 70 keV was used on all 
methods [67,81]. 
 
Below a basic outline of the steps taken to convert CT numbers to PET is presented 
based on work done by Burger et al. in 2002: 
 
1. CT images interpolated to the resolution of the PET pixels 
2. CT values transformed from HU to PET attenuation coefficients 
 Eq. (1.3) 
where in Equation 1.3 𝑤 and 𝛽 represent water and bone respectively. Attenuation 
coefficients (μ, cm-1) represent the linear attenuation coefficients of PET 511 keV energy 
and the effective CT energy (80 keV) for water and bone [82–84]. 
 
3. Attenuation maps calculated from CT data are forward projected to the PET  
 
In their study regarding the transformation of CT into PET attenuation coefficients Burger 
et al. (2002) concluded a bilinear function/algorithm to consign CT values to PET is 
adequate for human tissue. They, however, determined their empirical PET attenuation 
coefficient value of 0.093 cm-1 produced more accurate results in the soft tissue range. 
Furthermore, they noted that the accuracy of high atomic number (Z) materials may be 
in question due to the photoelectric interaction of CT photons, at the lower energies (80 




to calcium (Z=20). Notwithstanding, a simulation study done by Xia et al. (2011) for a 
clinical setting of using “ultra-low dose” (tube voltage of 80 kVp) showed the feasibility of 
obtaining accurate attenuation maps. As part of their methods they varied tube current, 
tube voltage, filtration and smoothing techniques [85]. This study is relevant for preclinical 
even though a tube voltage of 80 kVp is at the high end for some preclinical. A similar 
simulation study with lower voltages and or greater divide (subsets) in >100 HU should 
be explored in order to determine accurate CT values of bones for improved attenuation 
maps. A more accurate high Z CT number is also applicable for the advancement and 
development of preclinical phantoms, enhanced image quality and quantification. 
 
3. Basic principles of positron emission and X-ray 
 
 3.1. Basic principles of PET physics 
 
The process of positron emission to detection is outlined and schematically shown 
below. The basic concept is thus: 
 
For positron decay (b+): as an unstable atom returns to a stable state via the weak 
interaction a proton decays to a neutron causing a positron and a neutrino to be emitted. 
The positron will travel a short distance (range dependent on positron energy, Table 1.2) 
before annihilating with an electron. This annihilation event results in the emission of two 
511 keV gamma (photon) rays travelling in diametrically opposite directions. Though b+ 
decay generates a spectrum of energy due to the emission of neutrinos, it is the distinct 
511 keV photons in coincidence from the annihilation that are detected by cylindrically 
arranged photodetectors. As the photons travel they will either be scattered, absorbed 
before reaching the scintillation crystals or enter the scintillation crystals. In the 
scintillator the absorption of the annihilation photons lead to the emission of scintillation 
light, which is then converted to photoelectrons for detection and counted. 
 
Starting with PET radiotracer injection: 
1. Positron emitting radiotracers are injected into a subject/patient, common 








Table 1.2: Commonly used PET radiotracers [86]. Positron range and energy is 
dependent on the injected positron emitting radiotracer. 





range in water 
(FWHM in mm) 
Production 
method 
11C 20.3 0.96 1.1 Cyclotron 
13N 9.97 1.19 1.4 Cyclotron 
15O 2.03 1.7 1.5 Cyclotron 
18F 109.8 0.64 1.0 Cyclotron 
68Ga 67.8 1.89 1.7 Generator 
82Rb 1.26 3.15 1.7 Generator 
 
Via decay, positrons emitted annihilate with electrons producing two 511 keV gamma 
rays (photons) at 180 ± 0.6 degrees in opposite directions, Figure 1.5 
 
Figure 1.5: Drawing of positron emission and annihilation with an electron producing two gamma 
rays. 
 
2. Photons are detected in coincidence (2 ns timing, and thresholding window for 
accepted energies, generally 400 to 700 keV to accommodate detector 






Figure 1.6: Schematic showing the process of coincidence detection of the gamma rays in PET. 
Modified from University of Washington, Introduction to PET Physics by Ramsey Badawi. 
 
The photons detected in coincidence mathematically (line integral) create a line defined 
as a line of response (LOR), which determine the signal (photons) position and strength 
to be used in the image reconstruction. Detection of photons are also referred to as 
counts or events. The measured number of events are proportional to the total 
radioactivity contained within the LOR. Coincidence detection of the photons can be 
classified as "true", “scatter” or “random” coincidences Figure 1.7: 
 
A. True coincidence: Both photons detected from the one annihilation and neither one 
has been scattered. 
 
B. Scatter coincidences: Two photons from the same annihilation event are detected 
within the timing and energy windowing, but one or both has undergone Compton 
scattering. 
 
C. Random coincidences: Detection of two photons within the coincidence timing but 
from different annihilation events. 
 
Scattered and random events will create an incorrect LOR for the reconstruction. They 













Figure 1.7: Drawings of gamma ray events: (A) true, (B) scattered (C) random. 
 
 3.2. Basic principles of X-ray physics 
 
X-rays are ionising electromagnetic radiation generated inside an X-ray tube (cathode 
and anode), Figure 1.8, in the following manner: 
1. Electrons in the electrical circuit consisting of high voltage input to a cathode with a 
tungsten filament are removed from this circuit by heat. The electrical current passing 
through the filament heats it causing electrons to be removed. 
 
2. Due to the potential difference between cathode and anode the electrons expelled 
from the cathode are attracted to the anode. As the electrons move towards the anode 
their velocity and kinetic energy increase while their potential energy decreases. 
 
3. The electrons are guided by the design of the cathode (cupped shaped) and anode 
(cut at an angle with a tungsten focal spot) inside a vacuum. 
 
4. The electrons bombarding the surface of the anode will interact with atoms. This 







Figure 1.8: Drawing displaying the basic/main components of an X-ray tube; cathode, filament, 
focal spot and anode. The drawing also indicates the flow of electrons expelled from cathode to 
anode then out as X-ray beam. 
 
These fast moving high energy electrons will interact with the nucleus or the shells of 
atoms as they penetrate the surface of the anode. X-rays emitted via interaction in the 
nucleus are called Bremsstrahlung due to "slowing" down the electrons; a deceleration, 
directional deflection and loss of energy, Figure 1.9 (A). The X-rays generated from the 
shells (K, L, M) are the characteristic X-rays, though rarely from the M shell. 
Characteristic X-rays are created when the incident electron's energy is greater than the 
binding energy of the shell electron. The ejection of the shell electron leaves a "hole" in 
which an outer electron will fill generating the X-ray, Figure 1.9 (B). The energy of 
characteristic X-rays are discrete (difference between shells). Whereas the 
Bremsstrahlung X-rays energies range producing a continuous spectrum, example in 
Figure 1.10. 
A                                                          B 
 
Figure 1.9: (A) schematic representing the principles generating Bremsstrahlung X-rays. (B) 





Figure 1.10. Calculated X-ray spectrums (distribution of the number of photons): characteristic X-
ray spectrum spike for L and K shells and Bremsstrahlung at the lower X-ray energies. 
 
This entire process generates a substantial amount of heat. Some anodes are designed 
to dissipate the heat by rotating, while others will have heat sinks. The tungsten focal 
spot will absorb and dissipate the heat. The focal spot is also used to influence the CT 
spatial resolution by changing the size (i.e. smaller size - improved spatial resolution). 
 
 3.3. Basic principles of tomographic reconstruction methods 
 
The mathematical details in reconstruction algorithms are beyond the scope of this PhD 
project. Though, it's important to outline the basic reconstruction methods used by the 
preclinical sites in this study. As these reconstruction methods play an important role in 
determining a PET standard protocol. Any imaging modality collecting line integral data, 
the sinograms, can apply the same mathematical methodologies. There are two types 
of reconstruction methods; analytical (inverse Radon transform) and iterative (statistical 
estimation/Poisson likelihood function). The filtered back projection (FBP) is analytical, 
whereas ordered subsets expectation maximization (OSEM) or maximum likelihood 
expectation maximization (MLEM) are iterative. The fine tuning of reconstruction 
algorithms is an active area of research. Currently, FBP and OSEM remain the most 





The FBP method is a 2D Fast Fourier Transformation (FFT), which is the same as 
applying a Fourier Transformation to the Radon Transformation. The Radon 
transformation is the quintessential integral projection data (signal) methodology. The 
Fourier Transform separates the continuous signal into its discrete frequency 
components. Directly taking a 2D FFT of the projection data (signal) mathematically 
reduces steps. After the FFT is applied, filtering takes place and an inverse FFT is 
applied to obtain the wanted image data. Diagrams of projections from a single point 
representing the back projection and FBP concept shown in Figure 1.11.  
 
In 2D, acquired projection data along the imaging planes perpendicular/mainly 
perpendicular (direct planes and cross planes) to the scanner axis is binned for 
reconstruction then stacked for a 3D volumetric image. More scanners are now acquiring 
projection data in a fully 3D mode (i.e. no septa), collecting the imaging planes 
perpendicular to the scanner axis and the oblique planes, diagram in Appendix 1. The 
fully 3D mode data sets are computationally demanding. Therefore, these data sets are 
rebinned. This allows for a significant reduction in data size while maintaining the ability 
to reconstruct the projection data using analytical or iterative methods. Rebinning 
algorithms basically project the oblique sinograms onto the transverse sinograms. In 
other words, the algorithm rebins the 3D data into a 2D stack for reconstruction. The two 
most common rebinning methods are single-slice rebinning (SSRB) and Fourier 




















Figure 1.11: (A): Back projection b(x,y, Φ), into an image reconstruction array of all values of p(s, 
Φ) for a fixed value, p(s, Φ) is the projection formed by integrating along the LORs at angle Φ. 
(B): visual representation of FBP. Modified from University of Washington, Introduction to PET 
Physics by Ramsey Badawi. 
 
However, blurring is created when using back projection reconstruction methods due to 
overestimation in the centre and less so at the edges. This can be seen as the "star" like 
artefact. Frequency filtering is a mathematical approach to remove this image blurring 




method. Essentially, FBP reduces the overestimation by applying a “weight” filtering 
which reduces values in the centre and accentuates values at the edges [1]. 
 
Below, Figure 1.12, are diagrams and pictorials representing projections P(s, Φ) of four 
sources showing the mathematical sinograms, which are formed by integrating along 
each LOR at each angle. The sinograms are named as such since they “trace” a 
sinusoidal path in the projection space. 















Figure 1.12: Example of the mathematical sinograms showing detection (A) to sinogram 
representations. (B) Projections from A to D are displayed as their individual sinograms which 
also shows difference in size and location of each source detected. University of Washington, 
Introduction to PET Physics by Ramsey Badawi. 
 
Iterative methods are more complex than FBP. The concept is to make an initial estimate 
of the radiotracer distribution and forward project that estimate. Then the estimate 
projection is compared to the measured and adjusted. Therefore, the process starts with 
an estimate of the image matrix, calculates a new base, then repopulates the matrix 
continuing up to the requested number of iterations and/or subsets. Both algorithms 
(MLEM and OSEM) are based on a method for maximizing the output; Expectation 
Maximization (EM). MLEM is the method for maximizing the Poisson Likelihood 
Function. The OSEM method is a variant of MLEM and applies subsets to assist with 
each estimate. A diagram of the iterative reconstruction process is shown in Figure1.13 
using an image matrix of 2x2 for simplicity. The OSEM method will, to a certain degree, 


















Figure 1.13: Flow diagram represents the mathematical iterative process for OSEM. These steps 
are repeated until the requested iterations over all projection data is completed. 
 
 4. From clinical to today's preclinical PET/CT 
 
In the development and history of PET/CT scanners animals have always played a 
significant role. Starting back in the 1970's with Brownell’s group at the MGH Physics 
Research Laboratory humans and animals were imaged. Both took part in the 
development of the PET scanner; the detector designs, the reconstruction techniques as 
well as in the validation for usage in research and clinical applications. In 1974 Brownell's 
group using their positron cameras (PC-1 and PC-II) successfully carried out lung, heart, 
brain, blood flow, metabolism and radiopharmaceutical studies using dogs, rodents and 




[38]. They led the way to the development of dedicated small animal scanners. It was, 
though, the desire and push for novel pharmaceuticals that really drove the need for 
dedicated small animal preclinical PET/CT scanners [89–92]. By the 90's the development 
of preclinical PET/CT scanners was in full swing. Multiple systems were being designed, 
such as the PET Methodology, from Bloomfield and Jones at Hammersmith Hospital, 
London, UK [93]. Their PET system had an axial diameter of 11.5 cm, a 5 cm field of view 
(FOV) with a spatial resolution of 4.4 mm [93]. However, considered one of the first fully 
functional small animal preclinical scanner was the Sherbrooke APD-PET, developed at 
Sherbrooke University, (Québec, Canada). The Sherbrooke scanner didn't become 
completely operational and available until 1996.  
 
Why did it take so long for a preclinical PET/CT? It seems straightforward - take a clinical 
PET/CT shrink the bore for a small preclinical PET/CT- no problem. Not so. Indeed, right 
away it became obvious that you can't just shrink a clinical scanner and expect it to 
perform with the necessary spatial resolution for small animal imaging. It wasn't only 
spatial resolution that impeded development. Multiple factors played a role in the delay 
of commercially available preclinical scanners. Economics reared its head. Feasibility 
and greater proof of this technology being directly translational to clinical applications 
was needed along with the assessment of the impact on animals undergoing regular 
imaging and optimal doses. Input function requirements, gating for motion and count 
rate/sample size were also issues [89,92,94–96]. However, foremost was detector design [96–
98]. 
 
Fundamentally, detector design is at the core of obtaining the optimal spatial resolution 
and sensitivity of a PET scanner. In PET physics the unchangeable limiting spatial 
resolution constraints are positron range (distance a positron will travel varies with 
radiotracer) and non-collinearity of the gamma rays emitted from the positron-electron 
annihilation. Basically, the first preclinical scanners displayed poor spatial resolution due 
to parallax errors caused mainly by detector ring and design. Hampered by these 
constraints, detector designs became critical for the success of a dedicated small animal 
PET scanner. Building such a scanner and obtaining the required spatial resolution for 
small animal imaging, therefore, took years of design ingenuity, bit of luck and the 
availability of new detector components. The PET detector research field expanded (and 




programmable micro-processing chips, PMT, silicon photomultipliers (SiPMs) and 
avalanche photodiodes (APD) improvements and development. New and old scintillation 
crystal (LYSO:Ce, BGO, GSO:Ce, LSO:Ce, LGSO:Ce, LYSO:Ce) combinations, sizes, 
discrete or continuous designs, stacking arrangements were tested [96,98,99]. Along with 
detector design developments the other factors could be tackled. For example, scanner 
sensitivity, count rate, signal sampling size and scatter correction improvements with 
detector design allowed for establishing animal doses. Improved spatial resolution via 
scintillation crystal designs and depth-of-interaction (where gamma rays interact within 
the crystal) calculations validated feasibility and functionality of preclinical PET for 
translation to clinical [100,101]. Additionally, during this time, scanner system 
standardisation was realised. The analysis of the Sherbrooke scanner's characteristics 
(spatial resolution, sensitivity, count rate, scatter corrections and image quality) set the 
foundation for the preclinical PET NEMA scanner performance guidelines [90,99]. By the 
end of the 20th century preclinical PET/CT scanners were a proven reality. 
 
For comparison consider Table 1.3, shows the characteristics of three early preclinical 
PET/CT scanners and a sneak preview of one of the preclinical scanner characteristics 
enrolled in this study. Scanner (1) is the Trifoil LabPET/CT enrolled in this study, scanner 
(2) is the Bloomfield’s group, (3) is Sherbrooke and scanner (4) is the microPET designed 
from the University of California, Los Angeles, CA, USA in 1999. 
 
Table 1.3: Different preclinical PET scanners properties testing results derived from 
literature [90,91,93,102]. 













16.2 7.5 2 x 2 x 
(12+13) 
APD 2.36 0.82 
2. BGO 11.5 5.0 30 x 50 x 
23 
PMT  4.4 
3. BGO 31.0 11.8 3 x 3 x 20 APD 0.51 3.1 
4. LSO:Ce 17.2 11.2 2 x 2 x 10 PMT 0.74 1.8 
 







5. Project aims (1,2 and 3) 
 
Throughout the chronological history of PET and CT one common thread was the lack 
of standardisation (including scanner required regular calibrations) in the preclinical 
PET/CT imaging platform. Furthermore, preclinical literature has shown protocols with 
increased CT scanning durations, consequently leading to an increase in small animal 
absorbed doses from X-rays, do not directly translate onto improved image quality [103]. 
These results are pertinent information when conducting longitudinal preclinical PET/CT 
studies. Moreover, this supports the need to investigate imaging outcomes from different 
protocols in order to avoid spurious quantitative comparisons and minimize radiation 
exposure to small laboratory animals. For quantitative accountability, consistency and 
reproducibility standardisation in preclinical research is imperative. This project 
examines several facets to achieve the goal of standardising routine preclinical PET 
imaging reconstruction protocols and CT acquisition protocols. In order to address the 
identified gaps in knowledge, develop standardised protocols, suggest CT dose 
regulations and improve animal welfare in the field of preclinical PET/CT imaging three 
aims will be achieved: 
 
Aim 1: Improve experimental design in preclinical PET/CT imaging protocols between 
research groups by investigating and comparing acquisition and reconstruction 
parameters in different platforms, with the aim to work towards standardisation of 
imaging protocols across sites. 
 
Aim 2: Assess the impact and significance of different PET/CT parameters on image 
quality and quantification across different platforms, while delivering the lowest doses to 
small animals as possible. 
 
Aim 3: Design and manufacture prototypes of rat and mouse anthropomorphic phantoms 
to be used instead of animals for development of improved PET/CT imaging protocols. 
 
As in the clinical setting, different manufacture scanner characteristics (geometries, 
hardware, efficiencies and data processing algorithms) will impact acquired images. 
Nonetheless, it is the empirical quantitative image data results that hold the key for 
setting a standard protocol across all scanner variabilities regardless of hardware or 




in the same manner on each different scanner to create the most accurate, precise, 
consistence and reproducible results that is being sought. In essence, neutralizing the 
manufactures' difference. This is the scope of this study - replacing scanner variability 
for scanner similarity to establish global standard imaging protocols. This is not a scanner 
intrinsic or extrinsic NEMA performance comparison study. Nor does this study address 
the need for standardisation regarding animal care and handling. It is the quantitative 
results from the currently used default/daily/general imaging protocols that are compared 
irrespective of scanner characteristics. 
 
Accomplishing aim 1 and 2 required personally visiting each site multiple times for the 
acquisition of n=3 imaging data sets for each protocol (sites and developed) per PET 
and per CT phantom as well as the CT ionising radiation measurements. 
 
6. Research questions 
 
In preclinical research involving small animals, reliable scientific practices and outcomes, 
colloquially speaking, go hand in hand with animal welfare. Each aim not only seeks 
improved, refined experimental methods and results but improved animal welfare by 
reducing CT ionising radiation doses and the number of animals used. Applying the 
NC3Rs principle of refinement and reduction aims 1 and 2 ask the research questions: 
 
1. Will standardising preclinical PET/CT protocols across multiple scanners reduce 
quantitative bias in image data, while maintaining image quality? 
 
2. Will refining preclinical PET/CT protocols across multiple scanners reduce the CT 
absorbed doses to small animals while maintaining image quality and quantification? 
 
The 3rd aim addresses the use of animals for the optimisation of study specific protocols. 
Thus, applying the NC3Rs principle reduction and replacement aim 3 ask: 
 
3. Can a tissue equivalent material (TEM) anthropomorphic rodent phantom be 






Therefore, the remaining chapters, as expected go through each aim setting out the 
method and results. Chapters 2 and 3 cover aim 1 for PET and CT, respectively. Chapter 
3 also includes aim 2 as this is directly related to CT only. Aim 3 is presented in Chapter 
4. Finally, Chapter 5 is an overall discussion. It needs to be noted that sections of 









As noted, the preclinical PET/CT community has undertaken efforts towards the 
development of guidelines regarding animal handling/preparation and scanner quality 
control testing [18,19,104–106]. Several preclinical studies evaluating PET National Electric 
Manufactures Association, NEMA NU 4 2008 performance also exist (NEMA 
performance literature in Table 2.1). However, this project took the novel approach of 
quantitatively evaluating the empirical data and image quality of the actual PET protocols 
used across the different sites and scanners. This approach, as shown in the following 
sections, revealed significant and concerning results. Whilst, setting a foundation for 
establishing a "least bias" standard imaging protocol base on the empirical imaging data 
results. 
 
First, routine/default (hereon referred to as default) PET protocols were evaluated for 
image quality and quantification biases using two commercially available preclinical PET 
phantoms. Default protocols were set either by the vendor or the site for their routine use 
of imaging small animals. Secondly, several different PET reconstruction methods were 
quantitatively analysed for standardisation. Finally, standardised protocols were 
determined from the least biases between all imaging data sets for uniformity, recovery 
coefficient (RC), spill-out ratio (SOR) and standard uptake values (SUV). 
 
2. Preclinical PET/CT systems enrolled in this study 
 
PET images were acquired on the five different preclinical PET/CT scanners enrolled in 
this study; Bruker Albira, Mediso nanoPET/CT, Sedecal Super Argus, Siemens Inveon 
and Trifoil LabPET/CT. The scanners have been arbitrarily labelled 1 to 5 for the analysis 
of results. Table 2.1 outlines the basic components and characteristics of the preclinical 
PET scanners in this study. The information is derived from the reported manufactures’ 
data sheets and published literature regarding preclinical PET scanner NEMA 
performance results [25,102,107–118]. The evaluation of scanner performance is not a 




information, outlining the variability between scanners enrolled in this study. Further 
reading on NEMA scanner performances and comparisons are referenced in Table 2.1  
 
Table 2.1: Different preclinical PET scanners properties and NEMA NU4-2008 testing 
results derived from literature and available manufactures’ data sheet [25,102,107–118]. 
 
 
3. Commercially available preclinical PET phantoms used in study 
 
In order to avoid animal biological variability and for a protocol baseline comparison two 
different commercially available preclinical PET phantoms were used. The PET image 
quality phantom was used for quantification of uniformity, RC and SOR and the PET rod 
phantom for evaluation of spatial resolution. A brief description of the two preclinical PET 













Table 2.2: Summary of PET commercial phantoms used in this study at each site, for 
the assessment of imaging data sets acquired with the default and standard protocols. 
Phantom Brief description Measurement 
PET Image Quality (IQ), 
Bartec: PH-60-00-50              
8 x 3.5 cm 
 
Three chambers: 
(1) two 8 mm cylinders, 
(2) central uniform region 
(3) five rods with diameters of 1, 2, 3, 
4, and 5 mm 
 
    
Spill over ratio, 
uniformity and recovery 
coefficients 
 
Phantom Brief description Measurement 
microPET rod, QRM: 
MicroPET HotRod      
 7 x 3.5 cm 
 
Set of 6 triangular patterns with rods of 
diameters:  




4. PET materials and methods 
 
Quantitative biases were evaluated from the acquired phantom imaging data sets on 
both the default and developed standard protocol. A schematic of this process is shown 


















































































































































 4.1 PET acquisition method 
 
PET images were acquired as a single bed position for a duration of 20-minutes, energy 
windowing of 250 - 700 keV with the phantoms placed at the frontend of the scanner 
bed, positioned inside the bore at the isocenter, aligning sagittal, axial and coronal 
planes. An activity of 10±6 MBq of 18F-FDG in 23 mL of distilled water was injected into 
a PET IQ phantom, which includes 5 hots rods 1-5 mm for RC, uniformity section and 
SOR section composed of 2 cylinders filled with non-radioactive water and air. Whilst, 
64±5 MBq of 18F-FDG in 24 mL of distilled water was injected into a PET rod phantom 
containing 0.6, 0.8, 1.0, 1.2, 1.5 and 2.0 mm rods. PET doses were chosen based on 
the range of activities consistent with typically reported injected doses into small animals 
(10-50 MBq on average) as well as the purpose and design of the PET phantoms. All 
PET imaging IQ phantom data sets per scanner were acquired as n=3 for the analysis.  
 
 4.2. Reconstruction methods 
 
Emission data was reconstructed using the sites' default protocols. Protocols are listed 
by scanner (1-5), method (ordered subset expectation maximization (OSEM) or 
maximum likelihood expectation maximization (MLEM)), voxel size, filter and matrix size, 
Table 2.3. Scanners 2 and 3 also correct for partial volume effects by incorporating a 
point spread function (PSF) into the reconstruction algorithm. All scanners apply scatter, 
normalization and randoms corrections, whereas scanners 1-4 apply attenuation 















Table 2.3: Default PET reconstruction methods used at each site. 
Scanner Method Iterations 
*subsets or 
iterations 
Filter Voxel size (mm) Matrix size 
1 2D OSEM 2*16 Ramp 0.4x0.4x0.4 175x175x176 
2 3D OSEM 4*6 Ramp 0.4x0.4x0.4 108x110x110 
3 3D OSEM 2*18 Hamm 0.3x0.3x0.3 256x25x2566 
4 3D MLEM 12 NA 0.7x0.7x0.7 108x108x108 
5 2D MLEM 50 NA 0.5x0.5x0.5 200x200x200 
 
 4.3. Standardisation methods 
 
Standardising the PET protocol entailed evaluating the impact different reconstruction 
methods had on the quantification of the PET image data sets. The acquisition protocol 
was a 20 minute scan, same windowing parameters at each site. Therefore, the biases 
were assessed based on reconstruction methods. Developed standardised 
reconstruction protocols were derived from the default protocol analysis results as 
described above across all imaging data sets/scanners. The results which produced the 
least biases across all were chosen for the standard protocols. In addition, the actual 
PET reconstruction parameters available on each manufactures’ scanner were taken 
into consideration. The following reconstruction algorithms were tested: FBP, OSEM with 
a combination of iterations*subsets of 12, 16, 24, 30, 32, 48 and 64 and MLEM with 12, 
24, 25, 30, 32, 40 and 50 iterations. Quantitative analysis of the OSEM updates used in 
scanners 1, 2 and 3 revealed the optimal reconstruction methods were already being 
used for these particular scanners, (Section 5, Table 2.5). For that reason, focus was 
placed on optimising the MLEM method not only for improved accuracy but also for the 
best equivalent results to the OSEM method. Results were then evaluated in the same 





Quantitative assessment for standardisation of the PET imaging data noted above 
included uniformity, RC, SOR, and SUV. Numerical criteria for biases were based on the 
parameters in Table 2.4. 
 
Table 2.4. Criteria for quantitative analysis of PET results.  
PET IQ phantom  
Uniformity < 15% 
Recovery coefficients 1±10% 
Spill-out-ratio < 0.20 
Standard uptake value <10% bias 
 
Establishing a standard PET reconstruction protocol required each imaging data set (n=3 
per phantom) acquired on each scanner (n=5) to be quantitatively analysed and 
compared for the least bias between data sets. This was done between the reconstructed 
data sets within the same scanner and across/between the different scanners with the 
different reconstruction methods (OSEM, MLEM, FBP). The variability, percent changes 
were evaluated using the changes between the default reconstruction protocols and then 
between the standard reconstruction protocols being tested, listed above. Equation 2.1 
represents the percent differences. 
 
       Eq. (2.1) 
 
where d is the default empirical results being compared and s is the standard empirical 
results with units as per results being evaluated (RC, uniformity, SOR, SUV). Equation 
2.1 as noted was used to compare the differences between default protocol results within 
each scanner, (i.e. default result 1 between 2 and 3... n, result 2 between 3... n). This 
type of comparison was carried out between the tested standard as well. Microsoft Excel 
version 16.16.18 (USA) was used for these comparisons. Additionally, results were 








 4.4. PET phantoms 
 
4.4.1. PET IQ phantom 
 
For the PET IQ image analysis, reconstructed data was imported into PMOD version 
3.806 (PMOD, Zurich, Switzerland) and a MATLAB software tool implemented by Mediso 
(Mediso, Hungary). The Mediso MATLAB software program utilizes the NEMA NU 4-
2008 standards. The quantitative assessment of the PET data included uniformity, RC, 
SOR and SUV. In accordance to NEMA, uniformity is reported as the percent standard 
deviation (%STD) from a 22.5 mm diameter by 10 mm long cylindrical volume of interest 
(VOI) over the uniform region of the phantom. RC is calculated based on values 
extracted (measured activity) from regions of interest (ROI) twice the diameter of each 
hot rod. The MATLAB program draws linear profiles along the hot rods in the axial 
direction. The mean pixel values of the linear profiles are divided by the mean pixel value 
of the uniform region, Equation 2.2 below [55,119]. 
 
        Eq. (2.2) 
 
ROIrod represents the mean measured activity (kBq/mL) from the hot rods (1, 2, 3, 4 and 
5 mm) and VOIuniformity is the mean activity concentration (kBq/mL) from the uniformity 
region of the IQ phantom.  
 
VOIs were drawn on each air and water chamber with SOR values calculated as ratios 
between the air or water chamber mean value divided by the uniformity mean 
measurement, Equation 2.3 [55,119]. 
 
        Eq. (2.3) 
 
VOIchamber represents the mean pixel value (kBq/mL) from each individual air or water 
chamber and VOIuniformity is the uniformity measurement stated above in Equation 2.2. 










displaying the regions of the IQ phantom (uniformity, RC and SOR), as well as, the 
placements of the drawn regions/volumes of interest are shown in Figure 2.2. 
A                                        B                                        C 
 
Figure 2.2: Screen shot of the Mediso’s MATLAB software tool for the PET IQ analysis displaying 
the regions of the IQ phantom (uniformity, RC and SOR) as well as the placements of the regions. 
Panel A top down shows the placement of the ROIs (each hot rod) for RC, panel B top down 
show the placement of the uniformity ROI and panel C shows the placement of the ROIs for the 
spill-out ratio, white air chamber, blue water chamber. 
 
The standard uptake value (SUV) is a prevalent quantitative value used to report the 
radioactivity/volume measured by the scanner. This volumetric metric is based on the 
amount of radioactivity injected kBq per mL into what is being imaged, in this case the 
PET IQ phantom. A SUV is normalised to account for administered radioactivity (i.e. 
radioisotope decay) and weight, (here - weight of the PET IQ phantom), as defined by 
Equations 2.4 and 2.5. 
 








          Eq. (2.5) 
 
R (kBq/mL) in Equation 2.4 represents the activity concentration measured by the 
scanner, where d represents the administered radioactivity (kBq) and W is the weight of 
the PET IQ phantom (kg). Equation 2.5 reveals the values used in the calculation of R 
by the scanner. They represent the scanner's global scaling factor (g) in kBq/mL, the 
average pixel value (r) in arbitrary units and acquisition time (t) in seconds [120]. 
 
The SUV results reported as g/mL were obtained first using PMOD’s SUV image 
calculation scaler tool with a phantom measured weight of 0.073 kg. After scaling, a 2.8 
mL VOI template was placed on the uniformity section of the PET IQ phantom for the 
extraction of SUV results. Representative image of VOI placements on the PET IQ 
phantom is shown in Figure 2.3. The scanner is calibrated using known activity measured 
in the dose calibrator and decay corrected. Measured SUVs are the mean SUV value 
extracted from PMOD. The average SUV value per scanner is the average of the mean 
SUVs per site for n=3 measurements. The SUV data is also presented as normalized to 
the mean SUV measurement per scanner. For analysis of variance, using Prism 8, 
(GraphPad, CA, USA) an ordinary one-way (ANOVA) test was applied on the SUV data 
(default, standard and FBP) with a 95% confidence interval and Welch's ANOVA post-
test. 
 
A                        B                                               C 
 
Figure 2.3: PMOD screen shot showing the VOI placement on the PET IQ uniformity region for 
SUV measurements. Panels (A), (B) and (C) display the VOI placement from axial, sagittal and 









4.4.2. PET rod phantom  
 
PET spatial resolution assessment was conducted based on a visual assessment of the 
acquired images using the PET rod phantom. Horizontal profiles (H-profile) were 
extracted through a centre cross section, which included the largest rods (2 mm) 
obtained using the PMOD image profile tool. 
 
5. Analysis of PET Acquisitions using Default and Standardised Protocols 
 
 5.1. PET IQ phantom  
 
The tested reconstruction methods were limited by the allotted parameters available on 
each manufactures’ scanner. As similar as possible iterative updates were used in the 
analysis. Table 2.5 shows results from the default reconstruction methods for evaluation, 
comparison and the establishment of a standard protocol. The data displays the 
uniformity, RC and SOR for each scanner. Sections are divided by scanners (1-5) in 
which rows indicate the reconstruction method used and the data analysis results per 




















Table 2.5: PET IQ analysis: uniformity, RC, SOR for the default and tested different 
iterative and FBP methods. 
 
 
The RCs for hot rods of 1, 2, 3, 4 and 5 mm of the PET IQ phantom extracted for each 
scanner are shown in Figure 2.4. The default reconstruction methods are: scanners 1 
(2D OSEM 2 iterations 16 subsets), scanner 2 (3D OSEM 4 iterations 6 subsets, PSF), 
scanner 3 (3D OSEM 2 iterations 18 subsets, PSF), scanner 4 (3D MLEM 12 iterations), 
and scanner 5 (2D MLEM 50 iterations). The standardised protocol leaves scanners 1, 
2 and 3 with the default reconstruction method. Scanner 4 and 5 MLEM method is 
changed to 25 iterations instead of 12 and 50, respectively. The RCs for each site using 





Seen in Figure 2.4A, scanner 2 and 3 default reconstruction method overestimated the 
RCs by as much as 13% relative to 1 at the hot rod 3. Whereas, scanners 1, 4 and 5 
default reconstruction method underestimated the RCs. The RCs measured for scanners 
4 and 5 improved after implementing a standardised number of MLEM iterations at 25, 
shown in Figure 2.4B. A 43% difference measured between scanner 3 and 4 at the 3 
mm hot rod using default protocols was reduced to a 30% relative difference when using 
the standardised protocol. The FBP method produced the most consistent RCs of all 










































































































































































































Table 2.6 reveals poor image uniformity in scanner 5 before standardisation. The 
standardised reconstruction protocol (MLEM 25) improved uniformity in scanner 5 by a 
relative percentage difference of 36% (i.e. 16.7% to 10.6%). Though protocol 
standardisation improved scanner 5’s uniformity, there was no improvement in water and 
air SORs. This uniformity improvement was not observed in scanner 4 (MLEM 25), 
although its uniformity was already similar to OSEM data collected with other scanners. 
An improvement was seen in scanner 4's SORs for water and air. The mean uniformity 
value reduced by 12% when standardisation was applied (improved coefficient of 
variation from 67% to 37%).  
 
Table 2.6: PET IQ measured uniformity and spill-over-ratios (SOR) using the default 
reconstruction methods and the standardised reconstruction method. Values expressed 
as mean±standard deviation, n=3.  
 Default Protocol Standardised Protocol 
Scanner 
Uniformity 
(SD%) SOR water SOR air 
Uniformity 
(SD%) SOR water SOR air 
1 6.4±0.01 0.18±0.04 0.13±0.03 6.4±0.01 0.18±0.04 0.13±0.03 
2 4.1±1.00 0.09±0.01 0.09±0.01 4.1±1.00 0.09±0.01 0.09±0.01 
3 3.4±0.17 0.01±0.01 0.02±0.01 3.4±0.17 0.01±0.01 0.02±0.01 
4 5.2±0.60 0.28±0.04 0.22±0.04 6.4±0.00 0.21±0.00 0.13±0.00 
5 16.7±0.55 0.24±0.01 0.12±0.02 10.6±0.00 0.27±0.00 0.17±0.00 
 
The measured SUV and the expected values for each scanner using the default, 
standardised iterative method and FBP are displayed in Table 2.6. Analysis of the SUV 
variance proved significant for the default protocols and non-significant for the standard 
and FBP protocols (ANOVA: Default p<0.001, Standard p<0.205, FBP p<0.388 (FBP 
scanner 4 not included), n=3 per group). The greatest percentage difference (44%) in 
SUVs obtained using default protocols was between scanner 2 and 4. This was reduced 
to 14% with standardisation. Using FBP, the greatest percent difference of 6% was 




expected SUV and the average default SUV or to the standardised SUV was 18% and 
10%, respectively (Table 2.7 and Figure 2.5). The injected activity is decay corrected. 
The measured SUV values are also normalised to the average of the measured SUVs 
for each scanner per reconstruction method (Default, Standard and FBP).  
        Eq. (2.6) 
The values presented in the SUV normalised column are the average values; the 
average normalised value. 
 
Table 2.7: Measured and injected activity SUVs for each scanner using the default, 
standardised and FBP reconstruction methods. SUVs are the extracted mean and 



















1 3.61±0.34 3.24±0.19 1.04±0.06 3.24±0.19 0.96±0.05 3.26±0.08 1.03±0.02 
2 3.87±0.36 3.77±1.61 1.21±0.19 3.77±1.61 1.12±0.18 3.18±0.23 1.00±0.07 
 3 4.11±0.07 3.63±0.11 1.17±0.03 3.63±0.11 1.08±0.03 3.29±0.10 1.04±0.03 
 4 3.64±0.18 2.10±0.04 0.68±0.00 3.24±0.01 0.96±0.00 NA NA 
5 3.52±0.65 2.82±0.09 0.91±0.02 2.93±0.27 0.87±0.07 2.98±0.01 0.94±0.00 
Legend: NA=not available, FBP=filtered back projection. ANOVA: Default p<0.001, Standard 
















































































































































































 5.2. PET rod phantom 
 
Visual and horizontal profile analysis of the collected PET rod phantom data are shown 
in Figure 2.6. Images reconstructed with the sites’ default reconstruction methods 
showed the highest measured PET image resolution was 1.2 mm, as measured in 
scanner 3 and 5  (Figure 2.6A). When scanner 4 and 5 PET data were reconstructed 
using the standardised method 2.0 and 1.5 mm rods became well resolved in scanner 







Figure 2.6: Image slice and horizontal profile through the PET rod phantom. Panel (A): Scanners 
2, 3 and 5 resolved 2.0, 1.5 and 1.2 mm rods using default reconstruction protocols. Panel (B): 
Standardised reconstruction methods improved the spatial resolution of scanner 4 (2.0 and 1.5 
mm rods are seen) and essentially did not change the spatial resolution of scanner 5. Panel (C) 







The necessity for standardisation in clinical PET protocols was acknowledged and 
initiated nearly 20 years ago [121–124]. This recognition mainly stemmed from multi-centre 
trials focused in quantifying and tracking changes in malignant tumours as well as 
prognosis and treatment evaluations. Sadly, as stated throughout this thesis, 
standardisation is still lacking in preclinical PET imaging protocols. Today's preclinical 
PET/CT is a pivotal quantitative imaging research tool for translations to clinical 
applications supporting innovative research in areas such as disease diagnosis, 
prognosis and in the development of novel radiotracers and pharmaceuticals 
[2,6,8,15,17,125]. The empirical results revealed that the lack of preclinical protocol 
standardisation impacts quantitative image analysis, reproducibility and consistency 
across sites. Thus, limiting translational imaging data sets and impacting animal welfare.  
 
The significant quantitative differences measured across routinely used default protocols 
is concerning. For example, a commonly used analysis tool both in preclinical and clinical 
is the extractions of SUV measurements. An impacting factor on SUV measurements 
are the RCs and as shown the RCs greatly vary using different default reconstruction 
protocols. This is in line with previous reports on different PET reconstruction methods 
on image data quantification [126–128]. Discordant SUV measurements are not only 
revealed across sites but internally between scanner's different reconstruction methods. 
In particular, the measured 54% difference in SUV for scanner 4 when changing from 12 
MLEM to 25 MLEM. It was the FBP method that produced the most consistent and 
reproducible results across all scanners.  
 
The literature spanning reconstruction methods (from FBP to iterative) is vast. 
Unfortunately, currently there is not a single solution that adequately fits all scanners due 
to differences in scanner manufacturing. The recently published paper by Mannheim et 
al. (2019) measured PET uniformity, RC and SOR in the Siemens Inveon and Focus 
using the reconstruction method of 2D OSEM 4*16. This method differs from both the 
various default reconstruction methods revealed and from the standardised protocol 
designed. The study protocols in the Siemens platform produced similar uniformity and 
SOR but different RCs values from the five scanners (reconstruction methods) enrolled 




measurements given the improved precision of RCs and SUVs across sites. 
Nevertheless, using a combination of reconstructing with FBP and OSEM (as opposed 
to MLEM) serves the dual purpose of providing more accurate and precise quantitative 
information. The combined approach will also retain suitable image quality for better 
delineation of small organs and structures in preclinical animal species [130,131]. 
Therefore, it is recommended VOIs are drawn on the reconstructed OSEM image for 
better location/orientation then applied on the FBP image for accurate quantification. It 
is also recommended that the total number of updates (iterations*subsets or iterations) 
are no less than 24 and no more than 36 for analysis of image data in conjunction with 
using FBP. This set of iterations*subsets or iterations covers the range of OSEM and 
MLEM reconstructed data sets which produced the least biases amongst the different 
scanners.  
 
In 2017 Mannheim et al. (2017) pointed out the difficulties of establishing a standard 
imaging protocol due to different scanner technical parameters. Their study also 
discussed the potential impact the variety of technical parameters can have on the 
inability to reproduce research studies [132]. Here, taking the novel approach of 
quantitatively assessing imaging data sets default protocols produced as opposed to the 
scanner offered the opportunity to report actual numerical biases. Thus, overcoming the 
scanner technical parameter variability problem. Addressing the need for reproducibility, 
this study allowed for the ability to look at "end results" indicative of research. Acquiring 
results from each site's default PET reconstructions gave the foundation for direct 
empirical comparisons and analysis. From these comparisons, options for different and 
similar reconstruction parameters were identified and tested until a reduction in biases 
obtained. This task of analysing and comparing was not without limitations. Limitations 
revolved around reconstruction options available per scanner (OSEM, MLEM). Arguably, 
a primary concern. However, distinguishing similarities between methods by comparing 
numerical values as well as analysing the common method of FBP this limitation was 
vanquished. 
 
Imaging protocols producing unreliable and unreproducible imaging data sets is not the 
only concern. Mentioned early on, was the concern regarding scanner calibrations. 
Initially, the scanners at every site visited contained calibration errors and artefacts. With 




there is a system failure. Fortunately, the manufactures’ engineers responded 
expeditiously to rectify calibration errors and artefacts identified during site visits. 
Unfortunately, that may not always be the case. Scanner calibration, whether CT or PET 
procedures exist [55,56]. Therefore, along with standardising imaging protocols proper 
scanner calibration needs to be enforced. 
 
Additionally, animal welfare in preclinical PET imaging remains a great concern. Current 
literature exist discussing preclinical imaging handling and radiotracer injection protocols 
[104132]. However, the cycle of test re-test using animals essentially due to 
instrumentational protocol biases is still troubling. Implementing the standard protocols 
put forth will assist in ending this viscous cycle of repeating acquisitions or increasing 
group sizes to achieve meaningful PET imaging data.  
 
7. Conclusion  
 
This first standardisation aim set out to determine if improved experimental design, by 
investigating and comparing PET reconstruction parameters in different platforms, would 
in fact improve the precision and accuracy of imaging data sets. The question was: Will 
standardising preclinical PET protocols across multiple scanners reduce quantitative 
bias in image data, while maintaining image quality? Answer: yes, the imaging data 
comparisons across sites validated significant biases in PET outcome measures without 
standardisation. The implementation of preclinical PET/CT standardised protocols 
developed and tested will provide more robust, reliable and reproducible translational 
datasets for clinical applications. Moreover, in accordance with the NC3Rs principles, 
the refinement of PET protocols reduces unnecessary repeated studies and the number 









Clinically and preclinically CT is already extensively used in PET/CT and on its own, 
though without guidelines or standard protocols in the preclinical platform. Again, the 
approach of quantitatively evaluating the empirical data and image quality of the actual 
CT protocols used across the different sites and scanners was taken. For determining a 
global CT standard protocol, evaluating image quality and quantification biases was 
done using five commercially available preclinical CT phantoms. Each CT default 
protocol was also assessed based on measured absorbed ionising radiation. The 
standardised CT protocol was determined from the least HU biases between all imaging 
data sets.  
 
Measuring CT absorbed doses along with assessing HU value biases was always an 
initial important component of setting protocol parameters. However, it became apparent 
while visiting each site that the deficiency in understanding the amount of ionising 
radiation being absorbed per image was great. Along with establishing CT parameters 
for a standard protocol, this study's CT dose results provides the foundational work for 
establishing radiation dose guidelines.  
 
In addition to concerns over ionising radiation, site's scanner calibration was initially a 
concern. Though not a component of this study, it is important to emphasize the need 
for scanner calibration. Initially more than one scanner was plagued by calibration errors 
requiring intervention from the scanner manufacturer. Therefore, along with setting a CT 
protocol, correct calibration (HU values) at the different tube voltages needs to be 
ensured. 
 
2. Preclinical PET/CT systems enrolled in this study 
 
The five different preclinical PET/CT scanners enrolled and used for PET acquisitions 
were also used for the CT acquisitions. Scanners were arbitrary labelled the same way 
they were in Chapter 2. In Table 3.1 the basic characteristic of the CT component are 






















Albira 50 0-1 10 to 50 35 CsI:Tl 120 x 120 
Mediso 
nanoPET/CT 80 0-1 35 to 80 33 CsI:TI 150 x 120 
Sedecal 
Super Argus 50 0-1 4 to 50 35 CsI:Tl 120 x 120 
Siemens 
Inveon 80 0-500 35 to 80 < 50 Cs:TI 125 x 125 
Trifoil 
LabPET/CT 80 0-1 40-90 20-120 Cs:TI 165 x 165 
 
3. Commercially available preclinical CT phantoms used in study 
 
The same rational as in PET applies to CT. In order to avoid animal biological variability 
and for a protocol baseline comparison five different commercially available preclinical 
CT phantoms were used. Shown in Table 3.2 are the five different CT phantoms: CT 
air/water phantom and CT tissue-equivalent phantom (TEM) for measuring and 
quantifying Hounsfield (HU) bias, CT bar phantom for spatial resolution analysis, CT 
dose index rat and mouse phantoms to assess the absorbed dose (ionising radiation), 









Table 3.2: Summary of CT commercial phantoms used in this study at each site, for the 
assessment of imaging data sets acquired with the default and standard protocols. 
 
 
4. CT materials and methods 
   
For CT image acquisitions phantoms were placed at the frontend of the scanner bed, 
positioned inside the bore at the isocenter, aligning sagittal, axial and coronal planes. 
Images were acquired for the air/water, TEM and bar phantoms. All CT acquisitions were 
reconstructed using the FBP method. Schematic, Figure 3.1 displays the process of CT 













































































































































 4.1. CT acquisition method 
 
For each default protocol, CT basic acquisition parameters varied by tube voltages (kVp), 
number of projections and exposure time (ms) per scanner. Full CT default protocol 
parameters per scanner are listed in Table 3.3.  
 















1 circular 360 40 300 1:1 none 35 140 
2 circular 480 50 300 1:4 max FOV 33 520 
3 step-in-shoot 220 80 280 1:4 low < 6 500 
4 circular 250 35 300 1:4 none 35 200 
5 circular 256 50 555 1:1 low 33 760 
 
 4.2. Standardisation methods 
 
From the analysis of the CT data four standardised CT protocols were developed and 
tested. The tube voltage was set at 50 kVp and exposure time at 300 ms for all scanners 
with four varying number of projections (170, 360, 480 and 720 projections). Not all the 
scanners could set the projection parameters at 170 or 480. In those cases, data was 
only collected for the remaining protocols. CT collected data, including CT absorbed 
doses, were analysed in the same manner as the default protocols, as outlined above. 
In the CT result section, CT imaging data derived from default and standard acquisition 
protocols using 360 projections are presented, given that all scanners allowed for this 
setting. Presenting only these two data sets in the main results section also avoids the 
bombardment of copious amounts of data to read through. More importantly and to the 
fact or heart of the matter it was the 360 projection results that ended up fulfilling the 




said, it is important to show all the data analysis and results which lead up to the decision 
of the best suited standard protocol. Therefore, results from the other tested CT protocols 
are displayed in Appendixes 2 through 4 for reading. 
 
Establishing a standard CT imaging parameter protocol required each imaging data set 
(n=3 per phantom) acquired on each scanner (n=5) to be quantitatively analysed and 
compared for the least bias and variability between data sets. For the CT, this was 
accomplished by comparing numerical values acquired between imaging data sets when 
the imaging acquisition parameters were varied, as each site used the same 
reconstruction method (FBP). Similar to Chapter 1, the variability, percent changes were 
evaluated using the changes between the default protocol results and then between the 
standard protocol results being tested, listed above. From Chapter 1, now Equation 3.1 
represents the percent differences. 
 
       Eq. (3.1) 
 
where d is the default empirical results being compared and s is the standard empirical 
results with units as per results being evaluated (HUs for air, water, TEM and ionising 
radiation dose). Equation 3.1 as noted was used to compare the differences between 
default protocol results within each scanner, (i.e. default result 1 between 2 and 3... n, 
result 2 between 3... n). This type of comparison was carried out between the tested 
standard as well. Microsoft Excel version 16.16.18 (USA) was used for these 
comparisons. Additionally, results were compared to the criteria listed above in Table 
3.4. for least bias, reduced variability and/or for fitting the criteria requirements. 
 
Table 3.4: Criteria for quantitative analysis of CT HU results. 
CT Air/water phantom Air  Water  
  0 ±35 -1000 ±10   
TEM phantom Lung                Soft tissue (Adipose/muscle) 
Bone  
(Soft/cortical) 
 -600 to -700 ±10 -100 to 200 ±50 
400 to 800 ±50 
2000 to 3000 ±100 




Legend: * HU for TEM originally defined based on literature [71]. Preclinical HU ranges are not 
fully established. For example, water HU > 0 ±7 would be considered as failing in clinical CT 
calibrations. 
 4.3. CT phantoms 
 
4.3.1. CT air/water phantom  
 
Reconstructed CT data was imported into PMOD for analysis. A 5 mL VOI was placed 
on the air and water chamber of the CT air/water phantom to quantify the mean 
Hounsfield unit (HU) values, (Figure 3.2).  
 
A                             B 
 
Figure 3.2: PMOD screen shot showing the VOI placement on the CT water and air region for HU 
measurements. Panel (A) provide an axial view point and panel (B) displays a coronal view 
showing the water (left) and air (right) chambers. 
 
4.3.2. CT TEM phantom  
 
The TEM phantom data was imported into PMOD and individually co-registered with an 
in-house developed TEM phantom template in order to ensure correct and consistent 
placement of VOIs on each rod for each CT image. A VOI template was generated for 
each rod (0.008 mL for 2 mm and 0.05 mL 4 mm) for extraction of HUs, Figure 3.3. HU 
quantification accuracy was defined as bias between measured HU relative to 
established HU value for air, water and tissue. The data is represented as the mean 
±standard deviation (SD). Precision is assessed by measuring the SD and coefficient of 
variation (COV). For analysis of variance, using Prism 8, (GraphPad, CA, USA) an 
ordinary one-way (ANOVA) test was applied on the TEM data, grouped per tissue density 







A                                                    B 
 
Figure 3.3: PMOD screen shot showing the VOI placement on the CT TEM phantom rods for HU 
measurements. Panel (A) (axial view) and (B) (coronal) show the different size rods.  
 
In Figure 3.4 the location of the rods (4 mm, 2 mm and lung 5 mm) and their densities 
are displayed in Figure 3.3, though not to scale. The density values are those reported 
from the TEM phantom manufacture (CIRS). 
 
Figure 3.4: Schematic representation of panel (A) in Figure 3.3 showing the location and 
identification of the rods, along the manufacture's reported densities . Rods 1- 4 are 4 mm, rods 




The TEM phantom rods related to HU ranges based on the reported densities. TEM: rod 
density of 0.205 g/mL (lung) HU range of -600 to -700 ±10, rods with densities ranging 
from 0.95 to 1.115 g/mL (soft tissue) have an acceptable HU range from -100 to 200 
±50, rod density of 1.24 g/mL (bone) acceptable HU range is 400 to 800 ±50, rod density 
of 1.57 g/mL (cortical bone) acceptable HU range is 2000 to 3000 ±100 [71]. 
 
4.3.3. CT bar phantom  
 
CT spatial resolution was evaluated by visual assessment of the image obtained with the 
spatial resolution bar phantom. The number of structures (lines/dots with widths varying 
between 5 and 150 µm) on the bar pattern seen were compared to the manufacture’s 
size chart to estimate each protocol spatial resolution. 
 
5. Absorbed dose measurements 
 
An ionisation chamber probe (10x6-0.6 CT Therapy QA Chamber, detection range 1μGy- 
5kGy with ±4% calibration accuracy, Radcal, California, USA) was used for radiation 
dose measurements. The ion chamber probe was placed inside the CT dose index 
(CTDI) phantoms with the chamber in the centre FOV. Default and standardised CT 
protocol measurements were obtained (n=3) on all scanners with the mouse and rat 
CTDI phantom. 
 
The Radcal ion chamber software stops collecting/measuring at 300s. Previous work 
showed the measured CT dose with the RadCal probe is linearly dependent on scan 
length [103]. Therefore, CT protocols with a scan time longer than 5 minutes were 
measured to 300s then the dose was calculated based on remaining frames and 
measured dose, Equation 3.2. 
 
 
    Eq. (3.2) 
 
 












6. Analysis of CT Acquisitions using Default and Standardised Protocols 
 
Evaluating CT image data sets from all phantom results across site's default protocols 
revealed significant differences, including absorbed CT dose amounts. Scanner 5 does 
not output HUs. Therefore, scanner's CT results are a linear grey scale as opposed to 
HU. Numerical criteria for HU biases were based on the parameters in Table 3.4. 
 
 6.1. CT air/water phantom 
 
The HU extracted using CT default acquisition protocols for scanners 2 - 4 were within a 
global average range from these data sets for air of -989±13 HU (mean ± SD, n=3) and 
water 38±61 HU (mean ± SD, n=3). The greatest extracted HU for water was 133 HU 
and for air was -967 HU, measured in scanner 1. When the standardised CT protocols 
were applied results for scanner 1 improved (water HU improved from 133 HU to -77 
HU), while HU water results for scanners 2 - 4 were all within ±30 HU from 0 HU (Table 
3.5). The greatest measured HU for air when using CT standardised protocols was -990 
HU.  
 
Table 3.5: Hounsfield Units (HU) measured using the CT air/water phantom and default 
and standardised protocols. Results presented as the mean±standard error of the mean 
HUs for each scanner (n=3).  
Ave HU Water 
(0) 
Ave HU Air 
(-1000) 
1 Default 133.05±164.18 -967.86±85.59 
     Standardised -77.91±91.98 -990.46±50.97 
2 Default -29.62±18.64 -993.84±6.55 
     Standardised -27.88±20.55 -993.29±6.97 
3 Default 16.97±24.93 -994.98±9.67 
    Standardised 28.78±26.53 -996.92±4.13 
4 Default 24.85±14.11 -1000±0.00 
Scanner 5: one data set calibrated to HU (usual output is linear grey 
scale) 
5 Default -10.12 -1008.26 




Please note, the standardised protocol was acquired for scanner 4 but could not be 
quantified. The scanner's vendor/engineer was not able to  properly calibrate the scanner 
for the required tube voltage of 50 kVp. Hence, the data was nonsensical. Scanner 5 is 
not calibrated to measure HU values; output results are a linear grey scale. In order to 
report out HU for scanner 5 the data had to be converted manually based on the 
scanner's water and air calibration data. This conversion was done onsite by the site's 
in-house physicist, results are displayed on the bottom of Table 3.5. To illustrate the point 
and importance of correct CT scanner calibration Figure 3.5 displays artefacts observed 


































































































































































 6.2. CT TEM phantom 
 
A one-way ANOVA revealed significant differences across all tissue groups 
(p<0.0001, n=3), with the greatest variability (difference of 1581 HU, i.e. 
scanner means ranging between 3599 and 2018 HU) measured in the 1.57 
g/mL rod when CT default protocol methods were used. The three rods, 1.08, 
1.12 and 1.24 g/mL each measured mean percent differences greater than 
90%. The greatest mean percentage difference in the adipose rod was 147%, 
and muscle calculated greatest mean percent difference was 216%. The 
muscle and adipose rods also had calculated high mean standard deviations 
and coefficient of variation values, 67% and 104%, 77% and 66%, respectively. 
Lung measured the least bias, with the greatest mean percent difference of 
28%, a mean standard deviation of 75% with a coefficient of variation of 11%. 
 
Two scanners showed a high discrepancy in HU comparison between the 4 mm 
and 2 mm rods of the same TEM (1.08 g/mL and 1.12 mg/mL hydroxyapatite). 
Scanner 1 calculated percentage difference between the 4 and 2 mm 1.08 g/mL 
hydroxyapatite rods was 130% and scanner 3 measured percentage difference 
between the 4 and 2 mm 1.12 g/mL hydroxyapatite rods was 158%. All HU data 
points using the default protocols are shown in Figure 3.6A.  
 
The use of a CT standardised protocol improved quantitative precision for all 
the materials (Figure 3.6B). The greatest improvement was measured in the 
rods with densities of 0.21, 0.95 and 1.08 g/mL representing lung, adipose and 
soft tissue, respectively. For example, the quantitative precision for the rod 
representing adipose tissue (0.95 g/mL) improved from a standard deviation of 
77% with a coefficient of variation of 66% to a standard deviation of 22% and a 
coefficient of variation of 3% relative to the mean. Furthermore, the lung rod 
measured a reduction of mean differences, in which scanner 3 improved from 
a mean of -728.4 HU, standard deviation of 35.16%, to a mean of -738.4 HU 
with a standard deviation of 0.64%. Also, the 1.57 g/mL hydroxyapatite rod's 
measured mean difference was reduced by 67% between scanners from 1581 
to 518 HU. The muscle rod's measured HU values were the least improved with 
a standard deviation improved to 40%, the coefficient of variation remained 




The large percentage difference seen in scanner 1 between 4 and 2 mm 1.08 
g/mL rods when using default protocols reduced by 109% when standardised 
protocols were applied for CT data collection. However, in scanner 3, the 
measured percent difference between the 4 and 2 mm 1.12 g/mL 
























































































































































































































































































































































































































































































































Previously mentioned, scanner 5 is not calibrated to output HU values. Therefore, 
a linearity analysis was done on the grey scale output values for the TEM materials, 
Figure 3.7. The results indicate scanner 5's grey scale does change linearly with 




Figure 3.7: Plotted scanner's outputted grey scale values for CT TEM phantom. Grey scale 








 6.3. CT bar phantom 
 
Scanners 1, 2 and 4 were unable to resolve 150 μm lines using default protocols or 
distinguish the sections of lines/dots patterns. Scanner 5 had the highest spatial 
resolution for a default protocol of 150 μm (Figure 3.8A). A slight improvement 
(scanners 1-3) or no change in measured spatial resolution was seen when using 
the CT standardised protocol (Figure 3.8B). 
 
Figure 3.8: CT bar phantom images displaying QRM pattern for spatial resolution using the 
default (A) and post standardisation (B) of CT protocols. 
 
7. Analysis of measured absorbed CT radiation dose using default and 
standardised protocols 
 
Measured CT absorbed doses using the default protocols at each site ranged from 
11 mGy to 216 mGy (Table 3.6). Ionising radiation absorbed dose measurements 
in scanner 5 reduced by 81% when using the standard protocol. Overall there was 
a 48% and 40% reduction in the CT absorbed doses measured with the mouse and 











Table 3.6: CT absorbed doses determined using default protocols and a 
standardised protocol for mice and rats. Results expressed as mean±standard 








difference default to 
standard (%) 
(Eq. 3.1) 
Scanner Mouse Rat Mouse Rat Mouse Rat 
1 11±0.10 7±0.10 20±0.09 13±0.16 +77 +86 
2 40±0.11 28±0.02 31±0.23 21±0.08 -23 -23 
3 59±0.03 48±0.11 39±0.23 28±0.08 -34 -42 
4 32±0.18 15±0.10 56±0.76 25±0.05 +71 +60 




Unlike PET, the CT image reconstructions were all done, default and standardised, 
with the FBP method. Though like PET the quantitative biases revealed with the 
default protocols were substantial. The significant variations in HU from the various 
CT default protocols reiterates the necessity of standardisation. In this case the CT 
acquisition protocols have a more prominent role than reconstruction methods. 
Applying a standard CT acquisition protocol improved quantification precision of HU 
values across sites for each TEM measured as well as in air and water. The 
recommended standard CT protocol sets the tube voltage at 50 kVp for 300 ms with 




scanner enrolled in this study is capable of those parameters. Initiating the standard 
CT imaging protocol overcomes the scanner variabilities shown above in section 
4.1. Therefore, improving reproducibly of research results across sites. In addition, 
a set CT standard protocol assist in establishing CT dose guidelines [21,66]. 
 
Even though each scanner is capable of setting those CT imaging protocols 
parameter, each scanner did not successfully produce reasonable results. Already 
mentioned and shown, Figure 3.5, CT ring artefacts were seen in 4 of the 5 
scanners. More importantly, one scanner failed CT calibrations with a tube voltage 
of 50 kVp and other voltages. Similar to PET, it is imperative CT calibrations are 
done correctly. To be reiterated in Chapter 5 section 1 and noted in Chapter 2, 
section 6 literature and general guidelines for scanner calibrations and quality 
control evaluations exists. For example, Vanhove et al. (2015) and Osborne et al. 
(2017) outline the basics of CT quality control and set out time frame for running 
scanner calibration and quality checks [18,64,104]. The failure of correct CT 
calibrations impacted this study. Thus, it will most likely impact other research study 
results wanting to quantify CT data. By the time of writing this thesis, scanner 5's 
data could only be assessed based on the default values. Multiple attempts were 
made by the engineer to rectify scanner 5's improper CT numbers. At that point (not 
part of this study), a new set of data was acquired for the site's manufacturer’s 
engineer as all CT calibrations were failing at multiple tube voltages. Hopefully, this 
will be resolved prior to any quantification of CT data for research. 
 
In section 7, results from the ionising radiation were reported. It should be noted the 
ion chamber CTDI measurement were chosen over using the thermoluminescent 
dosimeters (TLD) due to the ability of the ion chamber to measure the radiation 
dose over the whole body, x, y and z axis of the phantom. The ion chamber also 
provides an immediate real time read out of the ionisation occurring inside the 
chamber. The ionisation inside the chamber creates a current that is directly 
proportional to an ionising dose a small animal would absorb [133]. That is not to say 
TLDs are of no use. TLDs are an important and valid research tool for measuring 
and recording ionising absorbed doses, setting foundational work and continuing to 
do so regarding preclinical CT dose and radiation therapy [20,21,23,134,135]. The 
disadvantage of using them in this study was time, (TLDs are sent out to be read, 





The ion chamber CTDI CT absorbed dose results indicate standardised protocols 
produce a reduction of the average absorbed ionised radiation received by small 
laboratory animals, with no image degradation. Unfortunately, the change in tube 
voltage to 50 kVp in scanner 1 from 40 kVp and scanner 4 from 35 kVp with 
increased projections (250 to 360) led to an increase in the absorbed radiation dose. 
The amounts measured in the mouse and rat were increased by 77% and 86% in 
scanner 1. Scanner 4 measured an increase of 71% and 60% in the mouse and rat, 
respectively. However, even with the increase in scanner 1 and 4 all measured 
absorbed doses are now under limits of damaging ionising radiation absorbed 
doses reported in the literature (<60 mGy) [19,21,136,137].  
 
The large disparity and measured amounts of CT absorbed ionising radiation 
amongst sites is alarming. CT ionising radiation is known to have biological adverse 
effects. Clinically absorbed radiation doses have been regulated since the 1950s 
[138]. Overexposure of radiation will potentially cause unnecessary animal suffering 
and confound research outcomes [21,139]. Whether it's to be phase in or immediately 
implemented CT standardised protocols should be considered as a high priority. 
These results provide at a minimum the foundation for regulations regarding CT 
absorbed radiation doses. Following the NC3Rs principles refining and establishing 
CT protocols will reduce any potential animal suffering while reducing cumulative 
severity. Additionally, it will reduce the potential impact of biological responses from 
the radiation effect on research studies, especially in longitudinal imaging studies.  
 
On a side note, one of the most immediate and positive outcomes of measuring CT 
dose was bringing awareness to each site the amount of exposure a rodent was 
receiving every time a CT image was acquired. Establishing ionising radiation dose 
guidelines is a component of CT protocol standardisation that needs greater 




Chapter 3 encompassed aim 1 and 2. Here, the standardisation aim 1 set out to 
determine if improved experimental design, by investigating and comparing CT 
acquisition parameters in different platforms, would in fact improve the precision 
and accuracy of imaging data sets. The second aim addressed assessing the 




quantification, while delivering the lowest doses to small animals as possible. The 
two question were: (1) Will standardising preclinical CT protocols across multiple 
scanners reduce quantitative bias in image data, while maintaining image quality? 
(2) Will refining preclinical CT protocols across multiple scanners reduce the CT 
absorbed doses to small animals while maintaining image quality and 
quantification? The simple and straightforward answer to both those scientific 
questions is yes. The analysed data from the air/water and TEM phantom both 
showed standardisation improves precision and accuracy in CT image results 
across sites. A change in ionising radiation by changing CT default protocols did 
not degrade the image quality between default and standard. In fact, it was slightly 
improved in some cases. Overall, the proposed standard CT protocol reduced 





Chapter Four: Development of a TEM anthropomorphic rodent 





Traditionally, preclinical PET/CT phantoms are used for scanner quality control 
assurance and calibration. This holds true clinically as well. Clinically, phantoms are also 
used when designing PET/CT imaging protocols. If designing a preclinical experimental 
imaging protocol generally small laboratory animals are used. The development of 
anthropomorphic TEM phantoms, by using 3D-printing materials, has the potential to 
replace the use of animals all together when designing and optimising preclinical imaging 
protocols [18,72,140–144].  
 
The goal of this aim was and still is for the development of a tissue equivalent material 
(TEM) anthropomorphic rodent phantom to be used as a replacement for animals when 
optimising study specific PET/CT imaging protocols. Despite that, a tangent to this goal 
developed and discussion regarding other purposes such a phantom could be utilised 
for ensued. Therefore, without going into any great detail, another purpose for an 
anthropomorphic rodent phantom is in the field of oncology radiotherapy treatment. 
Preclinical radiotherapy studies are carried out using small animals, Monte Carlo 
simulations and more recently phantoms [23,145–149]. The development of a TEM 
anthropomorphic rodent phantom has proven to be feasible. Now research is expanding 
with greater detail to 3D printing, the material properties and anthropomorphic designs 
[23,148,150,151]. This subject will be brought back up in Chapter 5. 
 
Knowing the 3D material’s properties, such as the density, chemical composition, 
attenuation coefficients and the range or bias of measured HU using CT parameters, 
allows for the development of TEM 3D printed phantoms for preclinical PET/CT imaging. 
Understanding how the measured HU values of the 3D materials, specifically at the lower 
X-ray energy range of preclinical (30 – 80 kVp), correlate with actual tissue acts as a 
guide for the development and expansion of anthropomorphic TEM phantoms. 3D 




multiple materials at one time creating various layered designs. Consequently, these 
technologies represent a valuable tool for preclinical phantom development. 
 
Gaining the understanding of 3D printing materials’ properties using a range of X-ray 
energies was a necessary element of aim 3. It was the first step in sorting out 3D 
materials to use for printing. In order to do accomplish this, evaluating the attenuation 
coefficients of each material was undertaken. This involved; generating linear 
attenuation coefficients and the comparison between measured and calculated 
attenuation coefficients as well as comparison between calculated linear attenuation 
coefficients and tissue. From understanding the 3D material properties in relationship to 
X-ray energies suitable TEM materials for the development and printing of the phantom 
were eliminated or chosen. Finally, with the perceived optimal chosen materials a 3D 
TEM phantom was printed for HU analysis. 
 
Prior to delving into the evaluation of 3D printing materials and the production of a TEM 
phantom a brief 3D printing background is in order, section 2 below. Section 3 will outline 
the concept of attenuation. By section 4 details (materials and methods) of the study will 
be explained. Which leaves sections 5 and 6 to reveal the results. 
 
2. 3D printing technologies  
 
“Absorption, diffusion, dispersion and diffraction all contribute to the difficulties of working 
deep within the fluid medium on any economical and reliable basis” [152]. Therefore, in 
1984 Charles Hull filed and was granted patent number US4575330A, opening up the 
new industry of 3D printing, which today continues to grow. Hull’s design/invention 
combined computer generated graphics with stereolithography (printing thin layers of a 
curable material) [152]. Though, stereolithography, is still a common method for 3D 
printing, many other systems have been developed for a wide range of applications using 
a variety of materials. For example, just in the medical field 3D printed models of human 
organs have been incorporated; becoming an integral component in physician teaching 
aids producing realistic and accurate models, and based off patient images producing 





Currently, other than stereolighography the main types of 3D printing methods are: (1) 
Fused Deposition Modelling (FDM), (2) PolyJet/Inkjet, (3) Digital Light Processing (DPL), 
and (4) Direct Metal Laser Sintering (DMLS) [167–172]. Stereolighography creates an object 
using a vat of a liquid resin in which a UV laser cures the resin layer by layer based on 
the desired computer aided design (CAD) of the object [152,172,173]. DPL also uses a vat 
of liquid photopolymer material, however, the 3D object is built within the vat using an 
arc lamp and lens/mirror to focus the light underneath the vat to cure the designed object 
[170–173]. FDM utilizes CAD for the design development, in which the object is built with 
thin threads of material, forming a support structure as it builds the 3D object bottom up 
[172,173]. DMLS is another system which the design is created using CAD software. The 
unique option in DMLS is the use of metals. Here, powder metal alloys are thinly spread 
on a platform and the design is cured with a laser, building up the object and support 
material [170–172]. The Polyjet system uses standard tessellation language (STL) or 
computer aided design (CAD) to develop the model design. In this case, one or more 
liquid photopolymer materials are simultaneous piped/jetted through a head onto the 
platform forming the designed object, whilst being cured with a UV laser [170–173]. 
 
There are several factors to consider when choosing a printing method; some 
advantages to one system over the other are the choices of materials available including 
the option of using multiple materials for one object. Types of materials vary from metallic 
materials, polymers and polymeric composites (acrylonitrile butadiene styrene, nylon, 
polycarbonate, polyetherimide, polyphenylsulfone, polypropylene or rubber) [174–176]. Two 
of the regular Polyjet materials used in medical model designs are the acrylic based 
photopolymers Vero Clear and Tango Black. Perks et al. (2015) used Vero Clear, to 
create a 3D printed mouse phantom. In their study they investigated the accuracy of 
ionising radiation dosing from a clinical linear accelerator [23]. This study demonstrated 
the usefulness and the ability to develop and utilize 3D printed phantoms in research, as 
it allowed for the refinement of electron irradiation parameters and measurements 




Expanding upon the "usefulness" of utilizing 3D printing in preclinical research for CT 




the 3D printing materials sufficiently match rodent tissue HUs? Materials, such as acyclic 
and other polystyrene materials are already commonly used in phantoms. A prime 
example is the tissue equivalent material (TEM) phantom used in this study, Chapter 2. 
The main difference in using an anthropomorphic phantom opposed to the TEM phantom 
used is the multiple overlapping layers and thicknesses of the printing materials required. 
In the development of an anthropomorphic TEM phantom greater understanding of the 
attenuation of the X-ray energy through the 3D printing is a key component of its success. 
Hence, the emphasis on evaluating attenuation coefficients for the 3D materials and 
comparisons to tissue attenuation coefficients. 
 
To reiterate from Chapter 1; linear attenuation coefficients are dependent on the energy 
of the X-ray beam being emitted and the material the X-rays pass through. It is the 
attenuation of the X-ray beam through a material (also known as a medium) that is being 
measured in CT imaging. The X-rays can travel through, be impacted by photoelectric 
absorption (photoelectric effect) or scattered mainly by Compton scattering. A diagram 
showing the process of Compton scattering and photoelectric absorption is shown in 
Figure 4.1. The diagram of the photoelectric effect (B) is as previously presented in 
Chapter 1, Figure 1.9. Generally speaking how X-rays (photons/electrons) interact within 
a medium is determined by size of the particles and energy of X-rays; low energy X-ray 
might interact with an atom as a whole, whereas higher energy X-ray tend to interact 
with tightly bound electrons or at the nuclear level. Not shown in Figure 4.1, due to 
inconsequential impact, is the interaction with an atom as a whole - Coherent scattering. 
Coherent scattering is simply a deflection off the atom with no loss of energy. Compton 
scattering plays a role in CT and PET. For CT Compton scattering is prevalent in lower 
energies, typical in the Bremsstrahlung X-ray range. In Compton scattering the electron 
energy is transferred from the incident electron to the scattered. The energy transferred 
is governed by the angle of scatter (q). The photoelectric effect happens at higher 
energies, in which the initial (incident) electron energy is absorbed. Energy "absorbed" 
is actually transferred, causing an electron to be ejected, the incident electron to rebound 








A                                                                 B 
 
Figure 4.1:(A) schematic representing the principles of generating Compton scattering. (B) 
schematic representing the principles the Photoelectric effect. 
 
In Chapter 1 the relationship between attenuation and HU was presented. The accepted 















4. Phantom materials and methods 
 
 4.1. Background 
 
For the initial evaluation of 3D-printing material X-ray properties a data set from a 
previous study of measured densities and attenuation coefficients for twenty 3D-printing 
materials was obtained from Dr Nick Weir from the Department of Medical Physics, 
National Health Service (NHS) Lothian. The data set acquired by the Medical Physic 
NHS study was subsequently analysed for use in this study. Sections 4.2 and 4.3 outline 
the NHS study as well as explain the methods used for analysis and comparisons made 
between tissues densities and attenuation coefficients. This is followed by introducing 
the process of developing a 3D anthropomorphic rodent phantom; CT imaging, data 
analysis, computer phantom designing. 
 
 4.2. Generation of calculated attenuation coefficients 
 
The 3D materials from the NHS study were printed using stereolithography, in which 
single and blended materials of various densities were printed in slabs (150 mm x 150 
mm x 5 mm). The slabs of printed materials were provided by the commercial supplier 
Tri-Tech 3D, UK. The calculation of the densities were done by measuring the material 
mass on a precision balance with the measurement of volume done using a micrometer 
and digital ruler. Attenuation coefficient values of varying thickness (0-150 mm) were 
experimentally measured using the small profile solid state radiation Raysafe Xi 
Transparent detector (Billdal, Sweden) with the standard clinical Philips Optimus 50 X-
ray radiographic equipment (Amsterdam, Netherlands). Each material was X-rayed at 
0.5, 0.7, 2.9, 5.8 and 15 cm, as represented in Figure 4.3. The measurements were taken 
















Figure 4.3: Drawing represents the Medical Physics NHS experimental design measuring each 
material's attenuation coefficient varying tube voltage and material thickness. The thickness of 
each material was varied by changing the material position, i.e. different thickness are shown in 
(A) and (B). 
 
For the nine base materials out of the twenty 3D printing materials, element percent 
composition by mass was derived from manufacture safety sheets, X-ray 



































































































































































































For the calculation of X-ray data, the information in Table 4.1 was used in conjunction 
with the National Institute of Standards and Technology (NIST) tables of X-ray mass 
attenuation coefficients [177]. This was accomplished by using the X-ray mass attenuation 
coefficients of each constituent element known in the materials (Carbon, Hydrogen, 
Oxygen, Titanium, Phosphorus and Nitrogen at energies 5kV through 135kV (increments 
of 0.5kV) calculated with the percent per element, per element mass at each energy; 
using Equation 4.1 Computed results were divided by the NHS previously calculated 
material density, per energy value in order to obtain the calculated attenuation coefficient 












         Eq. (4.1) 
 





represent the element percent weight in the material, element 
atomic weight and the mass attenuation coefficient, respectively. Mass attenuation 





         Eq. (4.2) 
 
where 𝜌 is the previously calculated material density, density express as g/cm3.  
 
The calculated X-ray fluence spectrum was based off the known spectral characteristic 
of the X-ray tube in the NHS experimental set up and predetermined. The tube details 
for the calculated X-ray fluence were: tungsten target material, 13 degree anode angle, 
0% voltage ripple; aluminium attenuating material of 3.4 mm thickness. 
 
The calculated X-ray fluence spectrums for each material were generated by 
implementing the Microsoft Excel sumproduct function. This was done for X-ray energies 
spanning 5 keV to 135 keV, in increments of 0.5. For example, the process is shown 






           Eq. (4.3) 
 
E [µ/r] represents the attenuation value of a specific atom at that X-ray energy, a and w 
represent the number of atoms and the atomic weight, respectively. Figure 4.4 shows 
the generated spectrum for Endur.  
 
Using the NHS predetermined X-ray tube fluence (keV), the computed µ (cm-1) values 
from Equation 4.2 and the material thickness (0.5, 0.7, 2.9, 5.8 and 15 cm) a calculated 
X-ray spectrum for the materials at each specific thickness was generated. Essentially, 
each calculated material’s spectrum (spanning 5 keV to 135 keV), for the distinct 
thickness and X-ray tube voltages were computed in the following manner: 
 
I= I0𝑒78N         Eq. (4.4) 
 
where I0 is the predetermined X-ray fluence (keV), 𝜇 represents the calculated linear 
attenuation coefficient from Equation 4.2 (cm1) and 𝑡 is the distinct material thickness 
(cm). 
 
In order to compare between calculated and measured attenuation coefficients, using I 
(keV) and the X-ray fluence energies the X-ray beam intensity was determined with 
Excel’s sumproduct function for the values ranging from 5 keV to 125 keV. The beam 
intensity calculation was repeated for all 9 materials at 60 kVp, 70 kVp, 81 kVp, 102 kVp 
and 125 kVp for each thickness. Once the beam intensity was determined using the 
below relationship from Equation 4.4: 
 
ln(I0/I)          Eq. (4.5) 
 


































 4.3. Preclinical CT acquisitions of 3D printing material  
 
All 3D printing material samples were individually imaged using the preclinical CT 
parameters listed in Table 4.2 on the nanoPET/CT scanner (Mediso, Hungry). Images 
were acquired with the materials placed at the frontend of a mouse bed, positioned inside 
the bore at the isocentre, aligning sagittal, axial and coronal planes. 
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Newly acquired and the nine 3D printing materials listed below were imaged using the 
developed CT standard protocol, Table 4.3. Figure 4.4 is an example of 5 different 3D 
printing materials; hard to rubber consistency. Image shows three varieties of Vero, 
Perspex and Tango Black. 
 
New materials used: 
Tango Plus FLX (930), Vero Black Plus RGD (840), Vero Blue RGD (835), Vero White 
Plus RGD (835) 
 
Original materials used:  
Endur, Heart Print Flex, High Temp, MED 610, Perspex, Tango Black Tango Black Plus 
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All acquired CT images were reconstructed with FBP and analysed using PMOD image 
analysis software (PMOD Technologies, Switzerland). A VOI (1.33 mL) was created for 
systematic placement on each material. This VOI was placed on the centre most area to 
extract the mean HU values (Figure 4.4F) for each material slab. Quantification accuracy 
was defined as bias between measured 3D-printing material's HU relative to known HU 
for tissue, based on Table 3.4, Chapter 3 and accepted tissue HU per literature [71]. 
 
A                            B                         C                        D                        E                          F 
 
Figure 4.4: Photographs of selected 3D-printing materials used in this study. (A) Vero Blue (B) 
Perspex, (C) Vero Clear, (D) Vero White and (E) Tango Black. From A to E there is a change in 
material density. Panel (F) is a representative image (axial and coronal planes in display) showing 
VOI placement on the CT acquisition for each material for HU measurements (F). 
 
 4.4. Process of developing a 3D printed anthropomorphic rodent phantom 
 
A CT acquisition of a scheduled 1 adult male Sprague-Dawley rat was exported into 
OsiriX v.7.0 (Bernex, Switzerland). OsiriX’s 3D volume and surface rendering tools were 
used for creating several 3D renderings; skeletal and whole body for references. The 
rodent's brain, heart, liver, kidney and lungs were imaged separately and exported in the 




files for exporting into Rhinoceros version 5.3.2 3D CAD software, (Seattle, WA USA). 
The STL files imported into CAD are mesh (polygons representing the geometric 
surface) files. This file format is essentially the surface geometry of a 3D object, created 
by the tessellation process of using overlapping triangles and interlocking triangular 
surfaces which cannot always be distinguished. This causes the removal and cleaning 
of unwanted surfaces and artefacts difficult. The CAD software is used to edit the STL 
mesh files. This process entails: (1) editing and separating out the scanner bed, (2) 
removing artefacts, (3) rebuilding tessellation surfaces, (4) filling holes, (5) aligning 
tessellation vertexes and (6) scaling the design. Figure 4.5 outlines the process, whilst 
Figures 4.6 through 4.11 display images of the process. 
 
The prepared CAD files were used for 3D printing with a Stratasys Objet 260 Connex 3D 
printer (Los Angeles, CA USA). The Connex printer simultaneously prints two 
polypropylene polymer materials, thus, allowing for the use of different whole body and 
organ materials. The phantom was designed with a void for lungs and a calcium 





































































































































































































After the bed is removed the process of editing, removing artefacts and rebuilding begins. 
Figure 4.7 illustrates this process, showing the removal and rebuilding. The skeleton 
required minimal rebuilding after being removed from the body, shown in Figure 4.8. As 
an example of the internal organ rebuilding, Figure 4.9 displays the brain and heart 
before and after editing. For a close up view of the issues faced in preparing the files 
Figure 4.10 shows the before and after versions of the head and abdomen section of the 
rat. The final figure in this process shows the completed whole body and a split of the 
body. The splitting of the CAD file was necessary in order to have the lungs as a void. 
When the files are printing the whole printed product is supported by a scaffolding 
material. This includes any internal void. Therefore, the only way to remove the 
scaffolding material was to split the files. It should be noted that the scaffolding material 
was X-rayed for HU measurements. These HU measurements were deemed to be 
unacceptable for lung, thus the scaffolding material was removed. 
 
 
Figure 4.7: Shows the STL files as seen in the CAD software. Panel (A) displays the mesh file 
voids/holes, overlapping surfaces and artefacts. Panel (B) represents the beginning process of 





Figure 4.8: The skeleton after being removed from the whole body is shown at its final stage for 
printing. The 3D printing of the skeleton file is done in the whole body and separately. 
 
A                                                      B 
 
Figure 4.9: Similar to Figure 4.7, Panel (A) represents the beginning process of removing 
artefacts, repairing and rebuilding for the brain. Panel (B) shows the same for the heart. 
 
A            before               after                      B   before                       after 
 
Figure 4.10: Shows the STL files as seen in the CAD software and the fully repaired version. Both 
panel (A) and (B) are zoomed in views. Panel (A) is the close up of the head showing the striking 





With all the files rebuilt (whole body, skeleton and all organs) the mesh files were then 
merged, scaled and split for printing, as shown in Figure 4.11. Each half of the phantom 
is printed separately. 
A                                                                                        B 
 
Figure 4.11: Image from the CAD software showing the mesh file repaired, rebuilt, cleaned and 
all vertexes aligned for printing. The phantom whole body with internal organs and skeleton can 
clearly be seen in panel (A). Panel (B) shows the split which allows for the removable of 
scaffolding material in the lungs. 
 
 4.5 Printing and CT acquisitions of the TEM anthropomorphic phantom 
 
Two prototype phantoms were initially printed on the Connex 3D printer. The first 
phantom was printed simply for printing design feasibility using Vero Clear for the body, 
Vero White Plus (M) for the internal organs and without the skeleton. The second printed 
phantom was split (each half printed separately) and used for HU analysis. This phantom 
was a combination of Tango Black Plus (M) for the body, voids for lungs and Vero White 
Plus (M) for brain, heart, liver, kidneys and skeleton. A CaHA capsule for HU analysis 




printed separately for design testing and assessment of the practicality of using a 
hydroxyapatite filler material, (CaHA capsule placed next to lung during imaging). 
 
Each phantom was placed at the frontend of the scanner bed as if it were a real rodent, 
positioned inside the bore at the isocenter, aligning sagittal, axial and coronal planes. All 
CT acquisitions were reconstructed using the FBP method. Images were acquired using 
the different CT protocols listed in Table 4.2 as well as the standard CT protocol listed in 
Table 4.3. These protocols are representative of (1) a CT low ionising dose, (2) a CT 
high ionising dose, (3) the scanner default and (4) the developed CT standard protocol. 
Reconstructed images from the second phantom prototype were exported to PMOD for 
HU analysis. VOIs were placed on the brain, heart, lung, CaHA capsule, both kidneys 
and liver, Figure 4.12. The same VOIs were placed on an imaged scheduled 1 adult male 
Sprague-Dawley rat for an additional preliminary HU comparison between the 3D 
materials and the phantom. As in previous HU analysis, quantification accuracy was 
defined as bias between measured HU relative to known HU for tissue, based on Table 
3.4, Chapter 3 and accepted tissue HU per literature [71]. 
 
A                                     B                                               C 
 
Figure 4.12: PMOD screen shot showing the VOI placement on the CT acquisition on the Tango 
and Vero Clear 3D printing phantom. Panel (A) is the placement on the brain, panel (B) displays 
the placement for the lung (green), heart (dark blue) and CaHA capsule (light blue) and panel (C) 
shows the liver (pink) and both kidneys (orange and red). 
 
5. Analysis of 3D printing materials  
 
 5.1. Calculated X-ray attenuation coefficient curves 
 
Presented below in Figure 4.13 are the generated attenuation coefficient curves for all 
nine 3D-printing materials. As the X-ray tube voltages increased the distinction between 





Figure 4.13: Calculated attenuation coefficient curves for all nine 3D-printing materials. Though 
values were calculated from 5 keV to 135 keV displayed is 30 keV to 120 keV for visual distinction 
between materials.  
 
 5.2. Calculated X-ray fluence spectrums 
 
Figure 4.14 displays the generated X-ray fluence spectrum for the material Endur at each 
voltage. Clearly seen are the characteristic peaks for the L and K shells as well as the 
Bremsstrahlung at the lower X-ray energies. 
 
Figure 4.14: Material Endur calculated X-ray fluence spectrum. Data presented as the distribution 
of the number of photons as a function of their energies.  

























Evaluating the calculated spectrums by material thickness and energy shows the familiar 
X-ray spectrum, Figure 4.15 at a tube voltage of 125 kVp. However, as seen in Figure 
4.16 the spectrums display more of the Bremsstrahlung X-rays at the lower X-ray tube 
voltages and with decreased thickness. The spectrums in Figure 4.16 represent each X-
ray tube voltage used for all five different thicknesses. The spectrums of the remaining 
eight 3D printing materials are shown in Appendix 5. 
 






Figure 4.16: Spectrums of the material Endur showing X-ray tube voltage of 102 (A), 81 (B), 70(C) 
and 60 (D) kVp for the 5 different thicknesses (cm) in which a measurement was obtained, with 
Bremsstrahlung X-rays clearly dominating at the lower energies. 
 
 5.3. Comparison of measured and calculated attenuation coefficients 
 
The calculated attenuation coefficients for nine 3D-printing materials were compared 
with the previously measured attenuation coefficients from the NHS study. Generating 
the analysis for comparison between the measured values and the calculated, required 
using equation 4.4 for each material at each thickness, then again for each tube voltage 
used (125 kVp, 102 kVp, 81 kVp, 70 kVp, 60 kVp). To reiterate, Equation 4.4. 
 
I= I0𝑒7[8]N         Eq. (4.4) 
 
Therefore, to calculate I (keV) , the predetermined X-ray fluence I0 (keV) was used with 
each material's calculated µ (Eq. 4.2) at each thickness used in the NHS study. Thus, 
giving I and I0. From Equation 4.5 (ln(I0/I)) the calculated attenuation values were 
determined for comparison with the measured. An example calculation process is shown 
in Table 4.4 using the material Endur. Each material, thickness and tube voltage was 
analysed and graphed. The measured attenuation coefficients are distinct values, 
whereas the calculated attenuation values are graphed as a continuous X-ray spectrum 




Table 4.4: Acquired measured (Medical Physics NHS study) and calculated attenuation 
for Endur at 125 kVp for each thickness. Table displays the process, steps per thickness 






















409144887 409144887 1 0 
0.50 0.14 409144887 360867474.9 1.13 0.13 
0.71 0.20 409144887 342702357.8 1.19 0.18 
2.89 0.76 409144887 201411198.4 2.03 0.71 
5.76 1.32 409144887 102174712.3 4.00 1.39 
15.00 2.09 409144887 12518330.18 32.68 3.49 
 
Figure 4.17 displays the relationship between the calculated attenuation coefficients and 
the measured attenuation coefficients with a tube voltage of 125 kVp at each thickness, 
for the material Endur. 
 
 
Figure 4.17: Comparison of calculated 3D material Endur at the X-ray tube voltage 125 kVp to 
each measured output at the defined thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
As noted above, comparison graphs between calculated attenuation and the measured 
attenuation for all nine 3D printing materials were generated at the designated tube 
voltages. Shown below in Figure 4.18 are the remaining graphs for the material Endur, 
displaying the results from the distinct tube voltages of 102 kVp, 81 kVp, 70 kVp and 60 






Figure 4.18: Comparison of calculated 3D material Endur at the X-ray tube voltage of 102, 81, 70 
and 60 kVp to each measured output at the defined thicknesses (0.5, 0.7, 2.9, 5.8 and 15 cm). 
 
It should be noted that the measurement for all the materials at all the voltages for the 
thickness of 15 cm is consistently below the calculated values. This is believed to be an 
experimental set up error when imaging the materials for 15 cm. The slabs were 
arranged at various angles to achieve the desired thicknesses; it is possible that the 15 
cm set up did not allow for the proper detection of the emitted X-rays. The thickness of 
15 cm is not practical owing to the typical thickness of rodents used in preclinical 
research. Therefore, the NHS experimental design was not repeated. The percent 
difference between the calculated and measured attenuation coefficient values were also 
tabulated. Table 4.5 displays the percent differences calculated for the material chosen 
for further use, remaining data tables are in Appendix 7.  
 
Using Equation 2.1 defined in Chapters 2 and 3, the 3D material Vero White displayed 




above 30% and as high as 71%. However, after discussions with the commercial 
supplier, Tri-Tech 3D, UK, the large discrepancy was deemed to be due to the poor 
quality of the actual printing, not the material. Overall the results indicated that the 























































































































































































































































































































 5.4. Comparison between calculated linear attenuation 
coefficients and known tissue attenuation coefficients 
 
Graphs were generated in order to assess the correlation between derived 
calculated linear attenuation coefficients and accepted human tissue linear 
attenuation coefficients, (Figures 4.19 through 4.21). The tissue attenuation 
coefficients were taken from NIST data tables [178]. 
 
Figure 4.19: Comparison of calculated material linear attenuation coefficients to 
accepted muscle tissue attenuation coefficients. Strong correlation between calculated 
and accepted is seen at energies above 75 keV and less so as the energy decreases. 
 
 
Figure 4.20: Comparison of calculated material linear attenuation coefficients to 
accepted bone attenuation coefficients. A decent correlation between calculated and 
accepted is seen at energies above 90 keV but substantial differences are seen less 





Figure 4.21: Comparison of calculated material linear attenuation coefficients to 
accepted lung tissue attenuation coefficients. Clearly evident, no material displayed a 
close similarity to lung. 
 
The calculated curves for all materials aligned well with muscle. Though the 
calculated curves correlate with cortical or trabecular bone at energies above 
90 keV, notably there are substantial differences under 90 keV. However, result 
shown in Figure 4.19 and Figure 4.20 demonstrate that energy ranges below 
80 keV still correlate well with soft tissue and soft bone. As seen above in Figure 
4.21, none of the 3D materials were remotely similar or equivalent to lung. 
 
6. Analysis of 3D printing materials imaged using preclinical X-ray 
tube voltages and the printed phantom  
 
 6.1. Measured HU evaluation of 3D printing materials   
 
Table 4.6 displays the results for nine materials at the four CT acquisition 
protocols. HU values for the 3D printed materials at these lower X-ray energy 
measurements were similar to the diagnostic clinical energy range, with the 
majority measuring well within the soft tissue range.  
 
3D-printing materials Endur yielded the highest (62 HU to 230 HU) and Tango 




protocol, all measured HU values were in line with the expected HU values for 
soft tissue, while 16 out of 20 and 19 out of 20 measured HU values were in 
line with the HU soft tissue values for low dose and the default CT protocol, 


































































































 6.2. Measured HU evaluation of 3D printed TEM anthropomorphic 
phantom  
 
Based on the comparison analysis between tissue and material HU as well as the 
availability of the 3D printing materials Tango Black Plus (M), Vero Clear and Vero White 
Plus (M) where chosen for the prototype printings. All were within a similar soft tissue 
range, shown in Table 4.7 and available. Vero White Plus (M) and Tango Black Plus (M) 
also served as "different" soft tissues values. 
 
Table 4.7: 3D printing material and HU used for printing TEM anthropomorphic phantom. 
CT acquisition was done using the standard preclinical CT protocol. 
Material Material density 
(g/mL) 
Average HU Standard 
deviation  
Tango Black Plus 
(M) 1.164 -38.60 22.32 
Vero Clear 1.175 -17.23 23.25 
Vero White Plus 
(M) 1.149 22.12 24.15 
 
Excluding the printed prototype, the decision to begin with Tango Black Plus (M) and 
Vero White Plus (M) was based on the idea of using two materials with a substantial 
difference in HU values. Under the same conditions, Tango Black Plus (M) has a 
measured HU of -38.60 whilst Vero White Plus (M) has a measured HU of 22.12. 
Therefore, even though both would be considered soft tissue, the concept was to 
measure how the materials measured as the X-ray beam attenuated through one then 
the other. How this would impact the HU values.  
 
In Figure 4.22 each 3D printing is shown, imaged with the standard CT protocol. As 
stated in section 4.5. The first phantom (Figure 4.2A) was printed using Vero Clear for 
the body, Vero White Plus (M) for the internal organs and without the skeleton. The 
second printed phantom (Figure 4.2B) was Tango Black Plus (M) to serve as the "skin" 
of the rodent phantom, encapsulating the other 3D printed components. With a 
measured HU value of -38.60HU this indicated X-rays would be less attenuated, pass 




was used to 3D print the brain, heart, liver, kidneys and skeleton components. The 
skeleton was printed with Vero White Plus (M) (Figure 4.2C). Seen in the images, the 
CaHA capsule is placed in the lung for the CT acquisition (Figure 4.2B & C). Images of 
the CT acquisitions using the four protocols with the second phantom are shown in 
Figure 4.23.  
 
A                                   B                                                     C 
 
Figure 4.22: CT images shown are with the standard protocol acquisition. Panel (A) is the printed 
prototype, (B) is the split phantom for testing HU. Panel (C) is a separate CT image of the 
skeleton, maximum intensity projection (MIP) image. A calcium hydroxyapatite (CaHA) capsule 

















A                         B                     C                      D 
 
Figure 4.23: CT images of the split phantom for each CT acquisition protocol; (A) standard; (B)  
default; (C) low dose; (D) high dose. 
 
The image quality is essentially indistinguishable between standard and default protocol, 
Figure 4.23 panels (A) and (B), respectively. Increased artefacts are seen in the high 
and low dose CT protocols, Figure 4.23 panels (C) and (D), respectively. The extraction 
of HU from the heart, lung, liver, kidneys and brain produced similar values for the 
standard and default protocols. The results are comparable across the standard, default 
and high protocols. Using Equation 2.1 to compare HU values between the CT protocols 
revealed substantial difference.  
 
      Eq. (2.1) 
 
in this incidence s represents the standard protocol and x is the other protocols or as 
noted in the text  
 
Deviating from the standard protocol produced the greatest percent difference in 
measured HU for the kidneys between the standard and low dose of 429%. The high 
dose HU deviation from the standard was greatest in the liver, 230%, Figure 4.24 and 
Table 4.8. The VOI placements for measuring the HU on each segment are shown in 
Figure 4.12. 




The HU percent differences comparing the phantom to the measured rat using Equation 
2.1, (s = measured rat HU, x = measured phantom HU) revealed the low CT dose 
produced the greatest differences. Shown in Table 4.9, the phantom HU using the low 
dose CT protocol was a 268% difference in the liver from the rat HU. The phantom CT 
low dose kidneys measured a 246% and 298%, left and right kidney respectively, 







































































Table 4.8: HU comparison between 3D printed anthropomorphic phantom standard 
protocol and the different protocols (default, high, low) HUs. 
Percent difference from the standard protocol (%) 





Default 44.31 -7.10 3.91 -0.24 16.71 39.25 7.51 
High 6.57 -21.22 -4.82 230.79 57.75 222.36 -0.97 
Low 102.50 58.80 74.43 323.72 294.76 429.21 111.57 
 
Table 4.9: HU comparison between 3D printed anthropomorphic phantom different 
protocols (standard, default, high, low) and measured rat HUs (default protocol).  
Percent difference from the measured rat HU (%) 





Standard 60.03 -56.98 24.98 24.77 39.77 36.63 
Default 77.74 -50.84 24.8 37.34 63.41 41.39 
High 62.65 -64.54 198.13 68.21 173.69 36.02 
Low 101 59.87 267.85 246.53 298.27 107.33 




Data analysis studies supports the feasibility and development of an 
anthropomorphic TEM rodent phantom using 3D printing materials for potentially 
replacing the usage of animals all together when optimising CT imaging study 
specific protocols. Previous studies using 3D printing materials for generic rodent 
phantom development have also proven successful [23,173,179]. Unfortunately, results 
revealed no material displaying a close similarity to the cortical bone. Nonetheless, 
the data does support using a CaHA material as a filler for the skeleton. Future work 
should include investigating further the use of ceramic calcium salts mixed with a 
polymer for simulation of denser bone tissue. Another option to consider and pursue 
is the possibility of using specialized 3D microstructure fabricated biomaterials. 
These materials are currently developed for tissue engineering and scaffolding for 




option, given that the materials are developed as printing materials. In addition to 
the 3D cortical bone material being a concern, the attenuation coefficient data 
indicated a 3D material for lung would also be an issue. To circumvent this, the first-
generation rodent phantom for analysis was printed with a void for lung. The 
measured HUs showed that a void, fortunately, produced compatible lung HUs for 
all the CT protocols. While this solution proved simple and practical the design 
needs to be questioned. Splitting the phantom produced air gaps along the phantom 
as can be seen in Figure 4.23. Thus, simple, practical but possibly not ideal. 
Creating a CAD design for printing the lungs as a "mesh" also remains an option. 
Overall, using the commercial 3D printer on site posed two main issues. The first 
being the limitations of materials available; availability of the material itself and the 
types of material usable on the printer. The second main issue, as discussed was 
the inability to print the design without splitting it, plus the inability of the printer to 
print three materials at the same time. 
 
The discrepancy of HU values measured from the rat compared to the phantom, 
especially seen in the CT low dose protocol (liver, kidney, brain) raises some 
concern. However, the rat measurements are only of n=1. Whereas, the results 
between rat and phantom for the other CT protocols and 3D printed organ segments 
are reasonable. Closer scrutiny is clearly called for not only in the use of different 
CT protocols, but in the HU values at the lower preclinical X-ray energies. As 
mentioned earlier, Hounsfield established the HU values using a tube voltage of 80 
kVp. A typical preclinical low dose CT would reduce the tube voltage to 35 kVp or 
less. 
 
Even with the current HU variability, design and printer concerns the developed 
anthropomorphic TEM phantom shows great potential as a tool to aid in the design 
and refinement of preclinical imaging experimental study specific protocols. It will 
allow for the tailoring of and testing of study specific protocols replacing any animals 
used in this process. Additionally, a phantom for this purpose reduces the likelihood 
of biological bias or variability introduced when using animals. 
 
8. Conclusion  
 
This third aim set out to design and manufacture a prototype rodent 
anthropomorphic phantom to be used instead of animals for development of 




to printed phantom to HU measurements, each step proved success of this aim. 
The question was: Can a tissue equivalent material (TEM) anthropomorphic rodent 
phantom be developed to eventually replace animals used when designing study 





Chapter Five: Final conclusions and future work 
 
This doctoral research set out to accomplish three main goals  
1. Improve experimental PET/CT imaging protocols through standardisation 
across sites. 
2. Assess the impact and significance of different CT parameters with the aim 
to reduce absorbed ionising radiation. 
3. Develop a prototype TEM anthropomorphic rodent phantom to be used 
instead of animals for designing study specific imaging protocols. 
 
Each of these goals were met with success. Nonetheless, each presented not only 
problems along the way, but a set of new research questions. The next and final 
three sections of this thesis will discuss the fruition of PET/CT standardisation, 
ionising radiation dose concerns, anthropomorphic phantom development issues 
and future work. 
 
1. Standardisation of preclinical PET/CT protocols 
 
Not until this study has establishing preclinical imaging standard protocols been 
directly addressed and set forth. The PET and CT empirical data collected from 
default protocols conclusively showed significant variability across every 
measurement taken, even within sites not just across sites, (Chapters 2 and 3). 
Looking at quantitative data for accuracy and precision, irrespective of scanner 
differences provided the opportunity to establish a standard imaging protocol, 
recapitulated in Table 5.1 below. Both PET and CT standards protocols are 
relatively straightforward, feasible on all tested scanner platforms and were shown 
to reduce biases (improve accuracy and precision) over all measurements within 
site and across site's datasets. 
 
Table 5.1A: Proposed preclinical PET standard reconstruction protocol for daily 
routine use regardless of scanner/site. 
PET reconstruction:  
Iterative algorithms OSEM or MLEM total updates (iterations*subsets or iterations) 
to be in the range of 24 to 36 - used to draw VOI and as a visual tool. 
FBP is recommended for quantitative analysis in conjunction with iterative methods. 





Table 5.1B: Proposed preclinical CT standard acquisition protocol for daily routine 
use regardless of scanner/site. 
CT parameters:  
Tube voltage set at 50 kVp with 360 projections and exposure time of 300 ms. 
 
Without a doubt everyone agrees that preclinical PET/CT scanner characteristics 
and capabilities vary from manufacture to manufacture. Therefore, the attainment 
of a standard protocol focused on the similarities in order to generate reproducible 
results irrespective of scanner. This approach has worked. During the course of 
data collection and at the time of writing this dissertation the implementation of the 
standard protocol has already begun. After data analysis was shared with sites, 
bringing awareness of the significance more than one site switched to the standard 
for all new research studies. These results generated discussions, launched other 
standardisation studies in PET/CT and were used in conference educational 
sessions. To date, fortunately, discussions regarding standardisation in PET/CT 
and other preclinical modalities continue amongst the imaging community globally. 
For example, the European Society for Molecular Imaging (ESMI) has established 
a coalition of preclinical imaging researchers, Standardisation of Small Animal 
Imaging (STANDARD) whose priority is to standardise preclinical imaging. In the 
United States of America, the Society of Nuclear Medicine and Molecular Imaging 
(SNMMI) preclinical research website now suggest nine topics for establishing 
imaging guidelines for the preclinical community. Two of those topics are the 
"development of standardise image format and data analysis". Both the ESMI and 
SNMMI recent initiatives hold promise for global preclinical imaging standardisation. 
The important factor is to get the word out, have the discussions, do due diligence 
- improve reliability.  
 
Generating continued said discussions, awareness and standardisation studies 
opens the avenue for further improvements. This also allows the opportunity to 
address additional preclinical imaging instrumentation concerns. A main concern 
noted at each site but one and throughout this study was the lackadaisical irregular 
calibration of scanners. The same sort of scanner quality assurance seen in the 
clinical setting should apply to preclinical - improving the robustness and translation 
of imaging data results. While it is important to test and verify scanner 
characteristics per accepted NEMA and ACRIN standards, it is as equally important 




scanner quality control/assurance avoids confounding factors generating spurious 
quantitative imaging results. 
 
Turning concerns directly to CT, furthermore, not until this study has the range of 
HUs values been measured at preclinical CT voltages across different scanners for 
evaluation. The traditional HU scale was established using clinical protocols with a 
higher tube voltage than 50 kVp [71]. As known and further shown, (Chapter 4), lower 
CT energies are dominated by Bremsstrahlung X-rays. To reiterate, attenuation 
coefficients are impacted by the initial ionising radiation and the medium they go 
through. Therefore, research, validation or clarification for a greater understanding 
of preclinical X-ray ranges and the relationship with HU is in order. The average HU 
values reported in Chapter 3 per TEM across multiple scanners can be used to 
establish or set a foundation for preclinical HU ranges, Table 5.2. Hence, these 
concerns lead to future work in this regard. For example, a possible extension of 
this work and validation of rodent HUs is to vary X-ray energies at preclinical tube 
voltage settings with rodent tissue density parameters in Monte Carlo simulation 
studies. Monte Carlo simulations can provide more detailed information on rodent 
tissue attenuation coefficients and then calculated HU values for comparison to 
measured values. 
 
Table 5.2: Proposed preclinical Hounsfield Unit (HU) range generated using the 
standard CT protocol (tube voltage at 50 kVp, 300 ms and 360 projections) and the 
tissue equivalent material phantom. Soft tissue and bone HUs are averaged using 
the 2mm and 4mm rods. 
Range of Hounsfield Units 
Lung range -778 to -686 
Adipose range -233 to -177 
Muscle range -8 to 64 
Soft tissue range  
   
(0.95 to 1.115 g/mL) -204 to 74 
Bone range  
   
(1.24 to 1.57 g/mL) 987 to 2900 
 
Furthermore, and as stated this work did not cover many other aspects of preclinical 




protocols. Some of the more recent literature on preclinical standardisation point 
out the critical issue of how animal welfare, handling and husbandry potential impact 
research and animals alike [104,184]. Literature from Osborne et al. (2017), Vanhove 
et al. (2015) and Kuntner et al. (2014) expand preclinical standardisation needs and 
considerations to include facility requirements, animal handling and husbandry as 
well as preclinical experimental designs [18,104,106]. These papers also point out the 
need for system quality control in preclinical imaging modalities. Recently, 
Mannheim et al. (2019) reiterated the concerns regarding animal handling [129]. 
Therefore, preclinical PET/CT imaging protocols is only a piece of the ongoing 
research and cry for standardisation in the preclinical imaging community. 
 
Currently, there are also ongoing discussions within the preclinical imaging 
community about requiring more transparent and explicit reporting of all 
procedures/protocols in published papers, which include the concept of using "open 
resources" for data files. A DICOM open source software, first for each site and 
ultimately available to be shared for researchers was discussed for data sets in this 
study. Therefore, all the imaging data sets were saved as DICOM files. This allowed 
for the same file format regardless of scanner or site. The difficultly of using an open 
source became apparent after the initial visits. The DICOM data sets pulled and 
moved off the different scanners sometimes ended up with missing information 
(DICOM headers), incorrect information (dates, bed positions). In order to avoid 
incorrect files and adding biases to the quantitative data analysis results it was 
decided all DICOM files were kept on a secure data base and loaded directly to 
PMOD. In the future the intention is to make the files available for researchers. 
 
2. Characterisation and reduction of absorbed ionising radiation  
 
The amount of ionising radiation being absorbed by small laboratory animals during 
even one default X-ray CT acquisition was unknown at every site enrolled in this 
project. The success of determining a standard protocol (detailed above) had an 
immediate impact on CT doses. Mentioned in Chapter 3 was scanner 5's high 
measured CT dose (>200 mGy). Due to animal welfare and the potential impact on 
research results, that site expeditiously decided to stop using their default protocol 
and adopt the standard protocol.  
 
It is known that ionising radiation has biological effects on cells and DNA; causing 




therapy is an active area of research preclinically and with Monte Carlos simulation 
studies [187,188]. However, to date the CT doses regularly received by laboratory 
animals through imaging remains widely unknown. Therefore, the potential 
biological responses from excessive CT radiation is a concern for animals and 
research results. The simple approach of switching a default protocol to a low CT 
dose is not sufficient. Future work in this area should expand to include in depth 
research into the effects of ionising radiation at preclinical energies on cell and/or 
DNA damage as well as the repair process from that damage. 
 
 On a positive note, the results from this doctoral research did show standardised 
protocols produce a reduction of the average absorbed ionised radiation received 
by small laboratory animals, (40% reduction, Chapter 3) with no image degradation. 
 
3. Anthropomorphic TEM rodent phantom  
 
The advantage of designing an anatomical phantom allows for the evaluations of 
X-ray attenuation through the different heterogeneous overlapping layers, organs 
and scatter. Therefore, a lot of focus, work and analysis was placed on the 
calculated and measured attenuation coefficients early on in the phantom 
development, the weeding out of materials. This weeding out is a vital component 
of the overall design decisions. If the TEM phantom is to be fully incorporated into 
use it is important the material's properties respond characteristically similar to 
tissue and organs when exposed to various X-ray beam energies. The attenuation 
coefficient results presented (Chapter 4) clearly indicated that several materials 
could be used for soft tissue. The measured HU also correlated well with the HU 
soft tissue range. Measured HU for lungs revealed that the void produced 
reasonable, acceptable values. A suitable and a feasible 3D printing bone material 
has yet to be identified. At this point, a fabricated bone biomaterial is most likely the 
solution. Currently, there are several research groups conducting successful tissue 
engineering (TE) fabrication studies for 3D printing [162,181,189] Biomaterials; 
degradable, non-degradable, synthetic polymers, natural polymers for a variety of 
uses are now available in academia as are modified 3D printers for handling 
biomaterials. The structural, mechanical and biological properties of cartilage is 
extensively studied in the TE field, providing a range of cartilage biomaterials; 
calcium composites, metals, ceramic oxides, hydroxyapatite [180,190]. In other words, 
future development of the anthropomorphic TEM rodent phantom should be moved 




with modified 3D printers to accommodate biomaterials will also possibly resolve 
the problem of splitting the phantom. Commercial 3D printers requires support 
material, whereas a modified printer can be stopped allowing for changing layers of 
materials. In 2018 Zhang et al. published similar findings to this work [151]. Their 
work however did not move forward to biomaterials and bone material 
requirements. 
 
Once fully developed the TEM anthropomorphic phantom's purpose has the 
potential to expand beyond imaging experimental protocol design. A future 
possibility is in dosimetry and radiation therapy studies. There is a growing interest 
in using small animals and/or phantoms as well as Monte Carol simulations in this 
regard [145,150,187,191]. Dancewicz et al.(2017) conducted a set of experiments using 
3D printed rods representing the various tissues (lung, soft tissue, brain, bone) and 
water as inserts into a phantom (Gammex phantom, Gammex Inc., Middleton , 
USA). For radiation therapy the CT tube voltages are substantially greater than the 
routine preclinical CT tube voltages [192]. Even so, they also concluded 3D printed 











Figure A1.1: Modified drawing from Dr Adam Alessio showing the difference between 2D and 
fully 3D measurements [1]. (A): Displays detectors with septa, in which 2D modes collects 
projection data in the direct and cross planes. (B): Represents the collection of fully 3D 
projection data, no septa allowing collection from the oblique planes (data is re-binned to 2D 





Appendix 2. CT air and water phantom measurements for non-standard 
tested protocols 
 
All CT protocols tested for a potential standard have a tube voltage of 50 keV and 
exposure time of 300 ms (as detailed in Chapter 2). The number of projections varied 
(170, 360, 480, 720) during the development of a standard CT protocol. Not all 
scanners were capable of the different number of projections, noted in the Tables 
below by NA (not available). As stated and reported in the main text of Chapter 2 
standard protocol is with 360 projections. 
 
Table A2.1: Hounsfield Units (HU) measured using the CT air/water phantom 
and default or 170 projections acquisition protocol. Results presented as the 
mean±standard error of the mean HUs for each scanner (n=3).  
Ave HU Water 
(0) 
Ave HU Air 
(-1000) 
1 Default 133.05±164.18 -967.86±85.59 
     170 projections NA NA 
2 Default -29.62±18.64 -993.84±6.55 
     170 projections -21.62±28.24 -998.56±13.05 
3 Default 16.97±24.93 -994.98±9.67 
    170 projections 32.23±37.18 -994.30±6.57 
Scanner 4 experienced failures; engineer work required; data reported 
as measured 
4 Default 24.85±14.11 -1000±0.00 
     170 projections -147.73±13.42 -1000±0.00 












Table A2.2: Hounsfield Units (HU) measured using the CT air/water phantom 
and default or 480 projections acquisition protocol. Results presented as the 
mean±standard error of the mean HUs for each scanner (n=3).  
Ave HU Water 
(0) 
Ave HU Air 
(-1000) 
1 Default 133.05±164.18 -967.86±85.59 
     480 projections NA NA 
2 Default -29.62±18.64 -993.84±6.55 
     480 projections -29.62±18.64 -993.84±6.55 
3 Default 16.97±24.93 -994.98±9.67 
     480 projections 26.69±23.33 -997.58±3.46 
Scanner 4 experienced failures; engineer work required; data reported 
as measured 
4 Default 24.85±14.11 -1000±0.00 
     480 projections -151.55±9.85 -1000±0.00 
























Table A2.3: Hounsfield Units (HU) measured using the CT air/water phantom 
and default or 720 projections acquisition protocol. Results presented as the 
mean±standard error of the mean HUs for each scanner (n=3).  
Ave HU Water 
(0) 
Ave HU Air 
(-1000) 
1 Default 133.05±164.18 -967.86±85.59 
     720 projections -82.30±72.74 -992.59±59.80 
2 Default -29.62±18.64 -993.84±6.55 
     720 projections -29.59±17.44 -993.71±6.53 
3 Default 16.97±24.93 -994.98±9.67 
     720 projections 29.56±19.00 -998.80±2.55 
Scanner 4 experienced failures; engineer work required; data reported 
as measured 
4 Default 24.85±14.11 -1000±0.00 
     720 projections -153.39±9.14 -1000±0.00 




























































































































































































































































































































































































































































































































































































































Appendix 4. CT dose readings for non-standard tested protocols 
 
Table A4.1 CT absorbed doses measured using default protocols and CT 
protocol 170 projections for mice and rats. Results expressed as 










to 170 (%)  
Scanner Mouse Rat Mouse Rat Mouse Rat 
1 11±0.10 7±0.10 NA NA NA NA 
2 40±0.11 28±0.02 18±0.01 13±0.03 -54 -54 
3 59±0.03 48±0.11 19±0.02 13±0.12 -69 -72 
4 32±0.18 15±0.10 36±0.02 16±0.11 +12 +7 






Table A4.2: CT absorbed doses measured using default protocols and CT 
protocol 480 projections for mice and rats. Results expressed as 










to 480 (%)  
Scanner Mouse Rat Mouse Rat Mouse Rat 
1 11±0.10 7±0.10 NA NA NA NA 
2 40±0.11 28±0.02 40±0.11 28±0.02 0 0 
3 59±0.03 48±0.11 53±0.17 38±0.11 -11 -21 
4 32±0.18 15±0.10 151±0.25 115±0.48 +371 +667 





Table A4.3: CT absorbed doses measured using default protocols and CT 
protocol 720 projections for mice and rats. Results expressed as 










to 720 (%)  
Scanner Mouse Rat Mouse Rat Mouse Rat 
1 11±0.10 7±0.10 40±0.13 27±0.14 +245 +270 
2 40±0.11 28±0.02 59±0.06 41±0.04 +47 +47 
3 59±0.03 48±0.11 81±0.00 57±0.14 +37 +20 
4 32±0.18 15±0.10 381±0.07 297±0.17 +1090 +1880 









Figure A5.1: Spectrums of the material Perspex showing X-ray tube voltages of 102, 81, 70 











Figure A5.2: Spectrums of the materials Med 160 showing X-ray tube voltages of 102, 81, 70 










Figure A5.3: Spectrums of the materials High Temp showing X-ray tube voltages of 102, 81, 











Figure A5.4: Spectrums of the materials Vero Clear showing X-ray tube voltages of 102, 81, 










Figure A5.5: Spectrums of the materials Vero White showing X-ray tube voltages of 102, 81, 











Vero White Plus: 
 
 
Figure A5.6: Spectrums of the materials Vero White Plus showing X-ray tube voltages of 102, 










Figure A5.7: Spectrums of the materials Tango Black showing X-ray tube voltages of 102, 








Tango Black Plus: 
 
Figure A5.8: Spectrums of the materials Tango Black Plus showing X-ray tube voltages of 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1. Standardisation of preclinical PET/CT imaging to improve 
quantitative accuracy, precision and reproducibility: a multi-center 
study. Journal of Nuclear Medicine, 2019, 27/09. 
doi:10.2967/jnumed.119.231308 
 
Preclinical Positron Emission Tomography/Computed Tomography 
(PET/CT) is a well-established non-invasive imaging tool for studying 
disease development/progression and the development of novel 
radiotracers and pharmaceuticals for clinical applications. Despite this 
pivotal role, standardization of preclinical PET/CT protocols, including CT 
absorbed dose guidelines, is essentially non-existent. This study: (1) 
quantitatively assesses the variability of current preclinical PET/CT 
acquisition and reconstruction protocols routinely used across multiple 
centers and scanners; and (2) proposes acquisition and reconstruction 
PET/CT protocols for standardization of multi-center data, optimized for 
routine scanning in preclinical PET/CT laboratory. Methods: Five different 
commercial preclinical PET/CT scanners in Europe and USA were enrolled. 
Seven different PET/CT phantoms were used for evaluating biases on 
default/general scanner protocols; followed by developing standardized 
protocols. PET, CT and absorbed dose biases were assessed. Results: Site 
default CT protocols: Greatest extracted Hounsfield Units (HU) for water was 
133HU and -967HU for air, significant differences in all tissue equivalent 
material (TEM) groups were measured. Average CT absorbed dose for 
mouse and rat was 72 mGy and 40 mGy, respectively. Standardized CT 
protocol: Greatest extracted HU  for water was -77HU and -990HU for air, 
TEM precision improved with a reduction in variability for each tissue group. 
Average CT absorbed dose for mouse and rat was reduced to 37 mGy and 
24 mGy, respectively. Site default PET protocols: Uniformity was 
substandard in one scanner, Recovery Coefficients (RCs) were either over 
or under estimated (maximum of 43%), standard uptake values (SUVs) were 
biased by a maximum of 44%. Standardized PET protocol: Scanner with 
substandard uniformity improved by 36%, RC variability was reduced by 




revealed important quantitative bias in preclinical PET/CT and absorbed 
doses with default protocols. Standardized protocols showed improvements 
in measured PET/CT accuracy and precision with reduced CT absorbed 
dose across sites. Adhering to standardized protocols generates 
reproducible and consistent preclinical imaging datasets, thus augmenting 
translation of research findings to the clinic. 
2. Multi-centre standardisation of preclinical PET/CT imaging: a 
necessary step towards achieving translational imaging datasets. Mol 
Imaging Biol. 2018;20(1):84. doi:10.1007/s11307-018-01305-2. 
 
Preclinical Positron Emission Tomography/Computed Tomography 
(PET/CT) is a key non-invasive imaging tool for studying disease 
development/progression and the development of novel radiotracers and 
pharmaceuticals for translation to clinical trials. Despite this pivotal role, 
standardization in preclinical PET/CT protocols is essentially non-existent. 
This project addresses such lack of global standardized preclinical PET/CT 
imaging protocols by evaluating biases across centers using default scanner 
protocols; followed by developing standardized protocols for optimisation of 
PET/CT imaging at multiple centers.  
 
Five different commercial preclinical PET/CT scanners in Europe and USA 
were enrolled in the study. Seven different phantoms were used: CT 
air/water phantom, CT tissue-equivalent phantom (TEM) for measuring and 
quantifying Hounsfield (HU) bias, CT spatial resolution phantom, CT dose 
index rat and mouse phantoms to assess the absorbed dose, PET image 
quality phantom for quantification of PET uniformity, recovery coefficients 
(RC) and spill-out-ratios (SOR), PET rod phantom for evaluation of spatial 
resolution.  
 
Site default CT protocols: greatest difference in extracted HU was 127% for 
water and 12% for air, measured TEM HU analysis indicated significant 
differences in all tissue groups (p <0.0001, one-way ANOVA, n=3 per group), 
ionized radiation absorbed doses ranged from 11.5 mGy to 216.1 mGy. 




179%, TEM analysis showed improved precision, CT absorbed dose was 
reduced by 81% in one scanner and an overall global reduction of 40%. 
Default PET: only two PET scanners resolved 1.2 mm rods; none resolved 
<1.0mm rods, one scanner's measured PET uniformity was substandard, 
RCs were either overestimated or underestimated (maximum of 43%) 
relative to expected activity, SUV values varied from 2.1 to 3.6 g/mL. 
Standardized PET protocol: improved uniformity by 36% in scanner with 
substandard uniformity, reduced RC variability by 13% points. 
 
Data revealed important quantification bias in PET and CT, as well as 
substantial variability in radiation absorbed doses across sites when using 
default protocols. This highlights the importance of preclinical PET/CT 
protocol standardization. use of standardized protocols showed 
improvements on PET uniformity, RC and improved precision in measured 
HU as well as CT absorbed dose reductions. Adhering to standardized 
protocols has the potential to improve reproducible and consistent imaging 
datasets, thus augmenting translational value of preclinical findings to the 
clinic. 
 
3. Multi-centre standardisation of preclinical PET/CT imaging: a 
necessary step towards achieving translational imaging datasets. Mol 
Imaging Biol. 2018;20(1):84. doi:10.1007/s11307-018-01305-2. 
 
Introduction: Preclinical Positron Emission Tomography/Computed 
Tomography (PET/CT) is a key non-invasive imaging tool for studying 
disease development and progression as well as for the development of 
novel radiotracers and pharmaceuticals. Despite this pivotal role, 
standardization of acquisition and reconstruction in PET/CT protocols is 
essentially non-existent. This project addresses such lack of global 
standardized preclinical PET/CT imaging protocols by evaluating biases 
across centres using default scanner protocols; followed by developing 






Methods: Six different commercial preclinical PET/CT scanners in Europe 
and USA were enrolled in this study. Eight different phantoms were used: 
CT air/water phantom to quantify Hounsfield (HU) bias in water/air, tissue-
equivalent phantom to measure HU bias in different tissue-equivalent 
materials (TEM), CT spatial resolution phantom, CT dose index rat and 
mouse phantoms to assess the absorbed dose, PET image quality phantom 
(PET uniformity, recovery coefficients (RC) and spill-out-ratios (SOR)), PET 
rod phantom (measurement PET resolution) and linearity phantom (noise 
equivalent counts (NEC). 
 
Results: Four scanners’ extracted HU values within expected range for air 
(-999±40HU), and water (34±95HU). One scanner had HU values in water 
of 133±284HU. Another scanner outputted CT results as a linear grey scale 
instead of HU (Fig. 1A). In general, measured TEM HU values were within 
expected range, apart from one scanner, which output was severely 
dependent on rod size (difference between 4 mm and 2 mm rod material up 
to 315%). Measured CT spatial resolution was on average 150 μm, though 
two scanners were unable to resolve 150μm lines using default protocols. 
Spatial resolution improved to 100 μm when using high-dose CT protocols. 
CT absorbed doses using default protocols at each site ranged from 11.5 
mGy to 268.2 mGy. Using the PET rod phantom, all but one scanner 
resolved 2.0, 1.5 and 1.2 mm rods; none resolved 0.6, 0.8 and 1.0 mm rods. 
Spatial resolution varied due to default scanner reconstruction algorithms 
used (maximum-likelihood expectation–maximization (MLEM) or ordered-
subset-expectation-maximization (OSEM)), each implementing different 
iterations and subsets (Fig. 1B). One scanner failed PET uniformity limit of 
15% and the SOR values were above 0.15. RCs were either overestimated 
or underestimated by a maximum of 16% at 3, 4, and 5 mm cylinders relative 
to expected activity.  
 
Conclusion: Data collected revealed important quantification bias in PET and CT 
preclinical protocols, and variability in CT absorbed doses across sites when using 
variable default protocols. This highlights the importance of preclinical PET/CT 




the enrolled sites in this seminal project could be expanded to other preclinical 
PET/CT sites globally. Adhering to standardized protocols has the potential to 
improve reproducible and consistent imaging datasets, thus augmenting 
translational value of preclinical findings to the clinic. 
 
4. High Dose MicroCT Does Not Contribute Toward Improved 
MicroPET/CT Image Quantitative Accuracy and Can Limit Longitudinal 
Scanning of Small Animals. Front Phys. 2017;5 (October):1-11. 
doi:10.3389/fphy.2017.00050. 
 
Obtaining accurate quantitative measurements in preclinical Positron 
Emission Tomography/Computed Tomography (PET/CT) imaging is of 
paramount importance in biomedical research and helps supporting efficient 
translation of preclinical results to the clinic. The purpose of this study was 
two-fold: (1) to investigate the effects of different CT acquisition protocols on 
PET/CT image quality and data quantification; and (2) to evaluate the 
absorbed dose associated with varying CT parameters. 
Methods: An air/water quality control CT phantom, tissue equivalent material 
phantom, an in-house 3D printed phantom and an image quality PET/CT phantom 
were imaged using a Mediso nanoPET/CT scanner. Collected data was analysed 
using PMOD software, VivoQuant software and National Electric Manufactures 
Association (NEMA) software implemented by Mediso. Measured Hounsfield Unit 
(HU) in collected CT images were compared to the known HU values and image 
noise was quantified. PET recovery coefficients (RC), uniformity and quantitative 
bias were also measured. Results: Only less than 2% and 1% of CT acquisition 
protocols yielded water HU values < -80 and air HU values < -840, respectively. 
Four out of eleven CT protocols resulted in more than 100 mGy absorbed dose. 
Different CT protocols did not impact PET uniformity and RC and resulted in <4% 
overall bias relative to expected radioactive concentration. Conclusion: Preclinical 
CT protocols with increased exposure times can result in high absorbed doses to 
the small animals. These should be avoided, as they do not contribute towards 
improved microPET/CT image quantitative accuracy and could limit longitudinal 
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